201
|
You SH, Qin XY, Xu C, Qiu X, Luan ZL, Jia HX, Wang HT. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016; 30:689-693. [PMID: 29771014 DOI: 10.13201/j.issn.1001-1781.2016.09.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Indexed: 11/12/2022]
Abstract
Objective: To observe the compliance, efficacy and safety of subcutaneous immunotherapy(SLIT) and sublingual immunotherapy(SCIT) in patients with allergic rhinitis(AR).Method:One hundred and fifteen patients sensitized to house dust mites were recruited in this study. The standardized extract of house dust mites was used for SLIT in 64 cases, and the standardized extract of dual house dust mites was used for SCIT in the other 51 cases. The compliance, nasal symptom scores, the medication scores, the quality of life and the adverse reaction were evaluated before and 2 years after immunotherapy. SPSS 19.0 was used for data analysis. Result:Forty patients out of 64 completed the 2 years-SLIT, and the compliance rate was 62.50%. Forty three patients out of 51 completed the 2 years-SCIT and the compliance rate was 84.31%.The compliance rate of SLIT was significantly lower than that of SCIT(P <0.05). The nasal symptom scores, the anti-allergic medication, the scores in quality of life decreased significantly after receiving SLIT or SCIT for 2 years(P <0.05). However, the changed values of scores between the two groups had no significant differences(P >0.05). There was no moderate or severe adverse reactions occurred in SLIT group but a total of 6 moderate or severe adverse reactions occurred in SCIT group.Conclusion:SLIT has same effect compared with SCIT with a lower compliance rate but a significantly higher safety.
Collapse
Affiliation(s)
- S H You
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - X Y Qin
- Clinical Laboratory, Chinese PLA General Hospital
| | - C Xu
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - X Qiu
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - Z L Luan
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - H X Jia
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China
| | - H T Wang
- Department of Otolaryngology-Head and Neck Surgery, Chinese PLA General Hospital, Beijing, 100853, China.,Department of Otolaryngology-Head and Neck Surgery, Hainan Branch of Chinese PLA General Hospital
| |
Collapse
|
202
|
Adamson P, Ader C, Andrews M, Anfimov N, Anghel I, Arms K, Arrieta-Diaz E, Aurisano A, Ayres DS, Backhouse C, Baird M, Bambah BA, Bays K, Bernstein R, Betancourt M, Bhatnagar V, Bhuyan B, Bian J, Biery K, Blackburn T, Bocean V, Bogert D, Bolshakova A, Bowden M, Bower C, Broemmelsiek D, Bromberg C, Brunetti G, Bu X, Butkevich A, Capista D, Catano-Mur E, Chase TR, Childress S, Choudhary BC, Chowdhury B, Coan TE, Coelho JAB, Colo M, Cooper J, Corwin L, Cronin-Hennessy D, Cunningham A, Davies GS, Davies JP, Del Tutto M, Derwent PF, Deepthi KN, Demuth D, Desai S, Deuerling G, Devan A, Dey J, Dharmapalan R, Ding P, Dixon S, Djurcic Z, Dukes EC, Duyang H, Ehrlich R, Feldman GJ, Felt N, Fenyves EJ, Flumerfelt E, Foulkes S, Frank MJ, Freeman W, Gabrielyan M, Gallagher HR, Gebhard M, Ghosh T, Gilbert W, Giri A, Goadhouse S, Gomes RA, Goodenough L, Goodman MC, Grichine V, Grossman N, Group R, Grudzinski J, Guarino V, Guo B, Habig A, Handler T, Hartnell J, Hatcher R, Hatzikoutelis A, Heller K, Howcroft C, Huang J, Huang X, Hylen J, Ishitsuka M, Jediny F, Jensen C, Jensen D, Johnson C, Jostlein H, Kafka GK, Kamyshkov Y, Kasahara SMS, Kasetti S, Kephart K, Koizumi G, Kotelnikov S, Kourbanis I, Krahn Z, Kravtsov V, Kreymer A, Kulenberg C, Kumar A, Kutnink T, Kwarciancy R, Kwong J, Lang K, Lee A, Lee WM, Lee K, Lein S, Liu J, Lokajicek M, Lozier J, Lu Q, Lucas P, Luchuk S, Lukens P, Lukhanin G, Magill S, Maan K, Mann WA, Marshak ML, Martens M, Martincik J, Mason P, Matera K, Mathis M, Matveev V, Mayer N, McCluskey E, Mehdiyev R, Merritt H, Messier MD, Meyer H, Miao T, Michael D, Mikheyev SP, Miller WH, Mishra SR, Mohanta R, Moren A, Mualem L, Muether M, Mufson S, Musser J, Newman HB, Nelson JK, Niner E, Norman A, Nowak J, Oksuzian Y, Olshevskiy A, Oliver J, Olson T, Paley J, Pandey P, Para A, Patterson RB, Pawloski G, Pearson N, Perevalov D, Pershey D, Peterson E, Petti R, Phan-Budd S, Piccoli L, Pla-Dalmau A, Plunkett RK, Poling R, Potukuchi B, Psihas F, Pushka D, Qiu X, Raddatz N, Radovic A, Rameika RA, Ray R, Rebel B, Rechenmacher R, Reed B, Reilly R, Rocco D, Rodkin D, Ruddick K, Rusack R, Ryabov V, Sachdev K, Sahijpal S, Sahoo H, Samoylov O, Sanchez MC, Saoulidou N, Schlabach P, Schneps J, Schroeter R, Sepulveda-Quiroz J, Shanahan P, Sherwood B, Sheshukov A, Singh J, Singh V, Smith A, Smith D, Smolik J, Solomey N, Sotnikov A, Sousa A, Soustruznik K, Stenkin Y, Strait M, Suter L, Talaga RL, Tamsett MC, Tariq S, Tas P, Tesarek RJ, Thayyullathil RB, Thomsen K, Tian X, Tognini SC, Toner R, Trevor J, Tzanakos G, Urheim J, Vahle P, Valerio L, Vinton L, Vrba T, Waldron AV, Wang B, Wang Z, Weber A, Wehmann A, Whittington D, Wilcer N, Wildberger R, Wildman D, Williams K, Wojcicki SG, Wood K, Xiao M, Xin T, Yadav N, Yang S, Zadorozhnyy S, Zalesak J, Zamorano B, Zhao A, Zirnstein J, Zwaska R. First Measurement of Electron Neutrino Appearance in NOvA. Phys Rev Lett 2016; 116:151806. [PMID: 27127961 DOI: 10.1103/physrevlett.116.151806] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Indexed: 06/05/2023]
Abstract
We report results from the first search for ν_{μ}→ν_{e} transitions by the NOvA experiment. In an exposure equivalent to 2.74×10^{20} protons on target in the upgraded NuMI beam at Fermilab, we observe 6 events in the Far Detector, compared to a background expectation of 0.99±0.11(syst) events based on the Near Detector measurement. A secondary analysis observes 11 events with a background of 1.07±0.14(syst). The 3.3σ excess of events observed in the primary analysis disfavors 0.1π<δ_{CP}<0.5π in the inverted mass hierarchy at the 90% C.L.
Collapse
Affiliation(s)
- P Adamson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Ader
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Andrews
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Anfimov
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - I Anghel
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - K Arms
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - E Arrieta-Diaz
- Department of Physics, Southern Methodist University, Dallas, Texas 75275, USA
| | - A Aurisano
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - D S Ayres
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - C Backhouse
- California Institute of Technology, Pasadena, California 91125, USA
| | - M Baird
- Indiana University, Bloomington, Indiana 47405, USA
| | - B A Bambah
- School of Physics, University of Hyderabad, Hyderabad 500 046, India
| | - K Bays
- California Institute of Technology, Pasadena, California 91125, USA
| | - R Bernstein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Betancourt
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - V Bhatnagar
- Department of Physics, Panjab University, Chandigarh 106 014, India
| | - B Bhuyan
- Department of Physics, IIT Guwahati, Guwahati 781 039, India
| | - J Bian
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - K Biery
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Blackburn
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - V Bocean
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Bogert
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bolshakova
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - M Bowden
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Bower
- Indiana University, Bloomington, Indiana 47405, USA
| | - D Broemmelsiek
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Bromberg
- Department of Physics and Astronomy, Michigan State University, East Lansing, Michigan 48824, USA
| | - G Brunetti
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Bu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Butkevich
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - D Capista
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - E Catano-Mur
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - T R Chase
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - S Childress
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B C Choudhary
- Department of Physics & Astrophysics, University of Delhi, Delhi 110007, India
| | - B Chowdhury
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - T E Coan
- Department of Physics, Southern Methodist University, Dallas, Texas 75275, USA
| | - J A B Coelho
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - M Colo
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - J Cooper
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Corwin
- South Dakota School of Mines and Technology, Rapid City, South Dakota 57701, USA
| | - D Cronin-Hennessy
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - A Cunningham
- Physics Department, University of Texas at Dallas, 800 W. Campbell Road, Richardson, Texas 75083-0688, USA
| | - G S Davies
- Indiana University, Bloomington, Indiana 47405, USA
| | - J P Davies
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - M Del Tutto
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P F Derwent
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K N Deepthi
- School of Physics, University of Hyderabad, Hyderabad 500 046, India
| | - D Demuth
- Math, Science and Technology Department, University of Minnesota-Crookston, Crookston, Minnesota 56716, USA
| | - S Desai
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - G Deuerling
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Devan
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - J Dey
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Dharmapalan
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Ding
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Dixon
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Z Djurcic
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - E C Dukes
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - H Duyang
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Ehrlich
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - G J Feldman
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - N Felt
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - E J Fenyves
- Physics Department, University of Texas at Dallas, 800 W. Campbell Road, Richardson, Texas 75083-0688, USA
| | - E Flumerfelt
- Department of Physics and Astronomy, University of Tennessee, 1408 Circle Drive, Knoxville, Tennessee 37996, USA
| | - S Foulkes
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M J Frank
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Freeman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Gabrielyan
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - H R Gallagher
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - M Gebhard
- Indiana University, Bloomington, Indiana 47405, USA
| | - T Ghosh
- Instituto de Física, Universidade Federal de Goiás, Goiánia, Goiás 74690-900, Brazil
| | - W Gilbert
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - A Giri
- Department of Physics, IIT Hyderabad, Hyderabad 502 205, India
| | - S Goadhouse
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - R A Gomes
- Instituto de Física, Universidade Federal de Goiás, Goiánia, Goiás 74690-900, Brazil
| | - L Goodenough
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M C Goodman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - V Grichine
- Nuclear Physics Department, Lebedev Physical Institute, Leninsky Prospect 53, 119991 Moscow, Russia
| | - N Grossman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Group
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - J Grudzinski
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - V Guarino
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - B Guo
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Habig
- Department of Physics and Astronomy, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - T Handler
- Department of Physics and Astronomy, University of Tennessee, 1408 Circle Drive, Knoxville, Tennessee 37996, USA
| | - J Hartnell
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - R Hatcher
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Hatzikoutelis
- Department of Physics and Astronomy, University of Tennessee, 1408 Circle Drive, Knoxville, Tennessee 37996, USA
| | - K Heller
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - C Howcroft
- California Institute of Technology, Pasadena, California 91125, USA
| | - J Huang
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - X Huang
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J Hylen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Ishitsuka
- Indiana University, Bloomington, Indiana 47405, USA
| | - F Jediny
- Czech Technical University in Prague, Brehova 7, 115 19 Prague 1, Czech Republic
| | - C Jensen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jensen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Johnson
- Indiana University, Bloomington, Indiana 47405, USA
| | - H Jostlein
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G K Kafka
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Y Kamyshkov
- Department of Physics and Astronomy, University of Tennessee, 1408 Circle Drive, Knoxville, Tennessee 37996, USA
| | - S M S Kasahara
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - S Kasetti
- School of Physics, University of Hyderabad, Hyderabad 500 046, India
| | - K Kephart
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Koizumi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Kotelnikov
- Nuclear Physics Department, Lebedev Physical Institute, Leninsky Prospect 53, 119991 Moscow, Russia
| | - I Kourbanis
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Z Krahn
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - V Kravtsov
- Department of Physics, Southern Methodist University, Dallas, Texas 75275, USA
| | - A Kreymer
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - Ch Kulenberg
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - A Kumar
- Department of Physics, Panjab University, Chandigarh 106 014, India
| | - T Kutnink
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - R Kwarciancy
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Kwong
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - K Lang
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - A Lee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W M Lee
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Lee
- Physics and Astronomy Department, UCLA, Box 951547, Los Angeles, California 90095-1547, USA
| | - S Lein
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - J Liu
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - M Lokajicek
- Institute of Physics, Czech Academy of Sciences, Prague, Czech Republic
| | - J Lozier
- California Institute of Technology, Pasadena, California 91125, USA
| | - Q Lu
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Lucas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Luchuk
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - P Lukens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Lukhanin
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Magill
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - K Maan
- Department of Physics, Panjab University, Chandigarh 106 014, India
| | - W A Mann
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - M L Marshak
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - M Martens
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Martincik
- Czech Technical University in Prague, Brehova 7, 115 19 Prague 1, Czech Republic
| | - P Mason
- Department of Physics and Astronomy, University of Tennessee, 1408 Circle Drive, Knoxville, Tennessee 37996, USA
| | - K Matera
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Mathis
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - V Matveev
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - N Mayer
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - E McCluskey
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Mehdiyev
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - H Merritt
- Indiana University, Bloomington, Indiana 47405, USA
| | - M D Messier
- Indiana University, Bloomington, Indiana 47405, USA
| | - H Meyer
- Physics Division, Wichita State University, 1845 Fairmout Street, Wichita, Kansas 67220, USA
| | - T Miao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Michael
- California Institute of Technology, Pasadena, California 91125, USA
| | - S P Mikheyev
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - W H Miller
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - S R Mishra
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - R Mohanta
- School of Physics, University of Hyderabad, Hyderabad 500 046, India
| | - A Moren
- Department of Physics and Astronomy, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - L Mualem
- California Institute of Technology, Pasadena, California 91125, USA
| | - M Muether
- Physics Division, Wichita State University, 1845 Fairmout Street, Wichita, Kansas 67220, USA
| | - S Mufson
- Indiana University, Bloomington, Indiana 47405, USA
| | - J Musser
- Indiana University, Bloomington, Indiana 47405, USA
| | - H B Newman
- California Institute of Technology, Pasadena, California 91125, USA
| | - J K Nelson
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - E Niner
- Indiana University, Bloomington, Indiana 47405, USA
| | - A Norman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Nowak
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - Y Oksuzian
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Olshevskiy
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - J Oliver
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - T Olson
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - J Paley
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Pandey
- Department of Physics & Astrophysics, University of Delhi, Delhi 110007, India
| | - A Para
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R B Patterson
- California Institute of Technology, Pasadena, California 91125, USA
| | - G Pawloski
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - N Pearson
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - D Perevalov
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Pershey
- California Institute of Technology, Pasadena, California 91125, USA
| | - E Peterson
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - R Petti
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Phan-Budd
- Department of Physics, Winona State University, P.O. Box 5838, Winona, Minnesota 55987, USA
| | - L Piccoli
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Pla-Dalmau
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R K Plunkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Poling
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - B Potukuchi
- Department of Physics and Electronics, University of Jammu, Jammu Tawi, 180 006 Jammu & Kashmir, India
| | - F Psihas
- Indiana University, Bloomington, Indiana 47405, USA
| | - D Pushka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Qiu
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - N Raddatz
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - A Radovic
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - R A Rameika
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Ray
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Rebel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Rechenmacher
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Reed
- South Dakota School of Mines and Technology, Rapid City, South Dakota 57701, USA
| | - R Reilly
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Rocco
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - D Rodkin
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - K Ruddick
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - R Rusack
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - V Ryabov
- Nuclear Physics Department, Lebedev Physical Institute, Leninsky Prospect 53, 119991 Moscow, Russia
| | - K Sachdev
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - S Sahijpal
- Department of Physics, Panjab University, Chandigarh 106 014, India
| | - H Sahoo
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - O Samoylov
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - M C Sanchez
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - N Saoulidou
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Schneps
- Department of Physics and Astonomy, Tufts University, Medford, Massachusetts 02155, USA
| | - R Schroeter
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J Sepulveda-Quiroz
- Argonne National Laboratory, Argonne, Illinois 60439, USA
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - P Shanahan
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B Sherwood
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - A Sheshukov
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - J Singh
- Department of Physics, Panjab University, Chandigarh 106 014, India
| | - V Singh
- Department of Physics, Banaras Hindu University, Varanasi 221 005, India
| | - A Smith
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - D Smith
- South Dakota School of Mines and Technology, Rapid City, South Dakota 57701, USA
| | - J Smolik
- Czech Technical University in Prague, Brehova 7, 115 19 Prague 1, Czech Republic
| | - N Solomey
- Physics Division, Wichita State University, 1845 Fairmout Street, Wichita, Kansas 67220, USA
| | - A Sotnikov
- Joint Institute for Nuclear Research Joliot-Curie, 6 Dubna, Moscow Region 141980, Russia
| | - A Sousa
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - K Soustruznik
- Charles University in Prague, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - Y Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - M Strait
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - L Suter
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R L Talaga
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M C Tamsett
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - S Tariq
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Tas
- Charles University in Prague, Faculty of Mathematics and Physics, Institute of Particle and Nuclear Physics, Prague, Czech Republic
| | - R J Tesarek
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R B Thayyullathil
- Department of Physics, Cochin University of Science and Technology, Kochi 682 022, India
| | - K Thomsen
- Department of Physics and Astronomy, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - X Tian
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - S C Tognini
- Instituto de Física, Universidade Federal de Goiás, Goiánia, Goiás 74690-900, Brazil
| | - R Toner
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - J Trevor
- California Institute of Technology, Pasadena, California 91125, USA
| | - G Tzanakos
- Department of Physics, University of Athens, Athens 15771, Greece
| | - J Urheim
- Indiana University, Bloomington, Indiana 47405, USA
| | - P Vahle
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - L Valerio
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Vinton
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - T Vrba
- Czech Technical University in Prague, Brehova 7, 115 19 Prague 1, Czech Republic
| | - A V Waldron
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - B Wang
- Department of Physics, Southern Methodist University, Dallas, Texas 75275, USA
| | - Z Wang
- Department of Physics, University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Weber
- Subdepartment of Particle Physics, University of Oxford, Oxford OX1 3RH, United Kingdom
- Rutherford Appleton Laboratory, Science and Technology Facilities Council, Didcot OX11 0QX, United Kingdom
| | - A Wehmann
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | | | - N Wilcer
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - R Wildberger
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - D Wildman
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Williams
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S G Wojcicki
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - K Wood
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Xiao
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Xin
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011, USA
| | - N Yadav
- Department of Physics, IIT Guwahati, Guwahati 781 039, India
| | - S Yang
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - S Zadorozhnyy
- Institute for Nuclear Research of Russian Academy of Sciences, 7a 60th October Anniversary Prospect, Moscow 117312, Russia
| | - J Zalesak
- Institute of Physics, Czech Academy of Sciences, Prague, Czech Republic
| | - B Zamorano
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - A Zhao
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J Zirnstein
- School of Physics and Astronomy, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, USA
| | - R Zwaska
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| |
Collapse
|
203
|
Cao Y, Yang Z, Yang X, Qiu X. OC-0359: Superficial dose verification of four dose calculation algorithms. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31608-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
204
|
Sun F, Zhou D, Wang Q, Feng J, Feng W, Luo W, Zhang D, Liu Y, Qiu X, Yin Z, Chen W, Xia P. The first report of detecting the bla SIM-2 gene and determining the complete sequence of the SIM-encoding plasmid. Clin Microbiol Infect 2016; 22:347-351. [DOI: 10.1016/j.cmi.2015.12.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2015] [Revised: 12/07/2015] [Accepted: 12/07/2015] [Indexed: 10/22/2022]
|
205
|
Adamson P, Anghel I, Aurisano A, Barr G, Bishai M, Blake A, Bock G, Bogert D, Cao S, Carroll T, Castromonte C, Chen R, Childress S, Coelho J, Corwin L, Cronin-Hennessy D, de Jong J, De Rijck S, Devan A, Devenish N, Diwan M, Escobar C, Evans J, Falk E, Feldman G, Flanagan W, Frohne M, Gabrielyan M, Gallagher H, Germani S, Gomes R, Goodman M, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn S, Hartnell J, Hatcher R, Holin A, Huang J, Hylen J, Irwin G, Isvan Z, James C, Jensen D, Kafka T, Kasahara S, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield P, Lucas P, Mann W, Marshak M, Mayer N, McGivern C, Medeiros M, Mehdiyev R, Meier J, Messier M, Miller W, Mishra S, Moed Sher S, Moore C, Mualem L, Musser J, Naples D, Nelson J, Newman H, Nichol R, Nowak J, O’Connor J, Orchanian M, Pahlka R, Paley J, Patterson R, Pawloski G, Perch A, Pfützner M, Phan D, Phan-Budd S, Plunkett R, Poonthottathil N, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin H, Sail P, Sanchez M, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga R, Thomas J, Thomson M, Tian X, Timmons A, Todd J, Tognini S, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb R, White C, Whitehead L, Whitehead L, Wojcicki S, Zwaska R. Measurement of the multiple-muon charge ratio in the MINOS Far Detector. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.93.052017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
206
|
Hu S, Ke S, Wang W, Ran H, Chen M, Zhang F, Qiu X, Jiang M, Zou C, Zhang R, Cao L, Wen Y, Fu R, Chen C. A single fas gene mutation changes lupus onset, severity, location, and molecular abnormalities in mice. Curr Mol Med 2016; 15:380-5. [PMID: 25941813 DOI: 10.2174/1566524015666150505162638] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2015] [Revised: 04/24/2015] [Accepted: 04/29/2015] [Indexed: 11/22/2022]
Abstract
Although genetic predisposition plays a major role in the progression of systemic lupus erythematosus (SLE) and its variation in symptoms, the precise relationships between genetic changes and disease status are not well understood. Here, to demonstrate the effect of a single gene mutation on disease etiology, we examined two mouse models of SLE with the same genetic background but different Fas genes. Mice with the Fas(lpr) gene developed severe SLE with renal dysfunction and inflammatory responses in the lung and kidney. By contrast, mice with the Fas(+) gene showed disease-related abnormalities in the liver and joints. Patterns of inflammatory disease markers differed across organs between the two lines of mice. Fas(lpr) mice showed greater MMP signals in the kidney and IL-11 signals in the lung than Fas(+) mice. Fas(+) mice had higher IL-11 signal intensity in the knee region and higher CXCR4 signal intensity in the liver than Fas(lpr) mice. Our results exemplify the complexity of disease and suggest the need for individualized target-specific treatment regimens. Strengths and Limitations of this Study: Fas gene is a well characterized gene in this disease. The molecular components in human disease need more clinical data.
Collapse
Affiliation(s)
| | - S Ke
- Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
207
|
Ouyang J, Sun F, Feng W, Sun Y, Qiu X, Xiong L, Liu Y, Chen Y. Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa. J Appl Microbiol 2016; 120:966-74. [PMID: 26808465 DOI: 10.1111/jam.13073] [Citation(s) in RCA: 147] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Revised: 12/22/2015] [Accepted: 01/11/2016] [Indexed: 12/12/2022]
Abstract
AIMS The study aimed to perform a systematic investigation of the effects of quercetin on biofilm formation and virulence factors in Pseudomonas aeruginosa. METHODS AND RESULTS The Ps. aeruginosa strain PAO1 was selected as the test strain. The results indicated that quercetin did not impact the growth of PAO1 as determined by MIC and growth curve analysis. However, this compound significantly inhibited (P < 0·05) biofilm formation and production of virulence factors including pyocyanin, protease and elastase at a lower concentration than those for most previously reported plant extracts and substances. Considering the central role of quorum sensing (QS) in the regulation of biofilm and virulence factor, we further detected the transcriptional changes associated with QS and found that the expression levels of lasI, lasR, rhlI and rhlR were significantly reduced (P < 0·05) by 34, 68, 57 and 50%, respectively, in response to 16 μg ml(-1) quercetin. CONCLUSIONS This study indicated that quercetin is an effective inhibitor of biofilm formation and virulence factors in Ps. aeruginosa. SIGNIFICANCE AND IMPACT OF THE STUDY This is the first study to demonstrate that quercetin is an effective inhibitor of QS, biofilm formation and virulence factors in Ps. aeruginosa. Furthermore, quercetin might have potential in fighting biofilm-related infections.
Collapse
Affiliation(s)
- J Ouyang
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - F Sun
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - W Feng
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - Y Sun
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - X Qiu
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - L Xiong
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - Y Liu
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| | - Y Chen
- Department of Pharmacy, Southwest Hospital of the Third Military Medical University, Chongqing, China
| |
Collapse
|
208
|
Cuffe S, Azad AK, Qiu X, Qiu X, Brhane Y, Kuang Q, Marsh S, Savas S, Chen Z, Cheng D, Leighl NB, Goss G, Laurie SA, Seymour L, Bradbury PA, Shepherd FA, Tsao MS, Chen BE, Xu W, Liu G. ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. Cancer Epidemiol 2016; 41:50-6. [PMID: 26816351 DOI: 10.1016/j.canep.2015.12.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2015] [Revised: 12/20/2015] [Accepted: 12/31/2015] [Indexed: 01/11/2023]
Abstract
BACKGROUND The drug transporter ABCC2 is upregulated in non-small cell lung cancer (NSCLC) and implicated in platinum resistance. We evaluated the association between germline polymorphisms in the ABCC2 gene and survival outcomes of platinum-treated advanced NSCLC patients. MATERIAL AND METHODS Ten candidate and tagging germline polymorphisms in the ABCC2 gene were genotyped in a discovery cohort of 170 platinum-treated stage IV NSCLC patients from the Princess Margaret Cancer Centre. Associations with overall survival were assessed using multivariate Cox proportional hazard models adjusted for prognostic variables. To validate our results, we analyzed the association of the two top polymorphisms in the ABCC2 gene on survival outcomes of 219 stage IIIB-IV NSCLC patients enrolled on the NCIC Clinical Trials Group BR.24 clinical trial. RESULTS Only one polymorphism was validated across both cohorts for an association with overall survival: the A allele of the ABCC2 polymorphism, rs8187710 (4544G>A), was associated with adverse overall survival (adjusted hazard ratio [aHR] 2.22; 95% CI: 1.2-4.0; p=0.009) among our stage IV NSCLC patients. A significant association with overall survival (aHR 1.73; 95% CI: 1.0-2.9; p=0.036) was observed for the same ABCC2 polymorphism in the BR.24 validation cohort. No other ABCC2 polymorphisms were associated with outcome. CONCLUSION The ABCC2 polymorphism, rs8187710 (4544G>A), is associated with overall survival in platinum-treated advanced NSCLC patients. Additional studies are needed to evaluate the predictive versus prognostic nature of this relationship, and to explore the functional effect of this polymorphism on the pharmacokinetics of platinum drugs.
Collapse
Affiliation(s)
- Sinead Cuffe
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada; HOPE Directorate, St James's Hospital, Dublin 8, Ireland.
| | - Abul Kalam Azad
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Xiaoping Qiu
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Xin Qiu
- Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
| | - Yonathan Brhane
- Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
| | - Qin Kuang
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Sharon Marsh
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
| | - Sevtap Savas
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada; Discipline of Genetics, Memorial University of Newfoundland, St. John's, NL, Canada
| | - Zhuo Chen
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Dangxiao Cheng
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Natasha B Leighl
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Glenwood Goss
- Division of Medical Oncology, Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada
| | - Scott A Laurie
- Division of Medical Oncology, Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada
| | - Lesley Seymour
- NCIC Clinical Trials Group, Queens University, Kingston, ON, Canada
| | - Penelope A Bradbury
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada; NCIC Clinical Trials Group, Queens University, Kingston, ON, Canada
| | - Frances A Shepherd
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| | - Ming Sound Tsao
- Department of Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
| | - Bingshu E Chen
- NCIC Clinical Trials Group, Queens University, Kingston, ON, Canada
| | - Wei Xu
- Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
| | - Geoffrey Liu
- Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, and Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
209
|
LI Y, Cui X, Qiu X, Ding C, Batool I. Management reference for nature reserve networks based on MaxEnt modeling and gap analysis: a case study of the brown–eared pheasant in China. Anim Biodiv Conserv 2016. [DOI: 10.32800/abc.2016.39.0241] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
210
|
Yu H, Qiu X, Behzad AR, Musteata V, Smilgies DM, Nunes SP, Peinemann KV. Asymmetric block copolymer membranes with ultrahigh porosity and hierarchical pore structure by plain solvent evaporation. Chem Commun (Camb) 2016; 52:12064-12067. [DOI: 10.1039/c6cc06402g] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Membranes with a hierarchical porous structure and an isoporous skin could be manufactured from a block copolymer blend by pure solvent evaporation (drying induced phase separation).
Collapse
Affiliation(s)
- H. Yu
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| | - X. Qiu
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| | - A. R. Behzad
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| | - V. Musteata
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| | - D.-M. Smilgies
- Cornell High Energy Synchrotron Source
- Cornell University
- Ithaca
- USA
| | - S. P. Nunes
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| | - K.-V. Peinemann
- King Abdullah University of Science and Technology (KAUST)
- Thuwal 23955-6900
- Kingdom of Saudi Arabia
| |
Collapse
|
211
|
Bhuckory S, Mattera L, Wegner KD, Qiu X, Wu YT, Charbonnière LJ, Reiss P, Hildebrandt N. Direct conjugation of antibodies to the ZnS shell of quantum dots for FRET immunoassays with low picomolar detection limits. Chem Commun (Camb) 2016; 52:14423-14425. [DOI: 10.1039/c6cc08835j] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Direct conjugation of IgG, F(ab′)2, and Fab antibodies to the ZnS shells of penicillamine-coated quantum dots for high-sensitivity FRET biosensing.
Collapse
Affiliation(s)
- S. Bhuckory
- NanoBioPhotonics (nanofret.com)
- Institute for Integrative Biology of the Cell (I2BC)
- Université Paris-Saclay
- Université Paris-Sud
- CNRS
| | - L. Mattera
- Univ. Grenoble Alpes
- INAC-SyMMES
- 38054 Grenoble Cedex 9
- France
- CEA
| | - K. D. Wegner
- NanoBioPhotonics (nanofret.com)
- Institute for Integrative Biology of the Cell (I2BC)
- Université Paris-Saclay
- Université Paris-Sud
- CNRS
| | - X. Qiu
- NanoBioPhotonics (nanofret.com)
- Institute for Integrative Biology of the Cell (I2BC)
- Université Paris-Saclay
- Université Paris-Sud
- CNRS
| | - Y.-T. Wu
- NanoBioPhotonics (nanofret.com)
- Institute for Integrative Biology of the Cell (I2BC)
- Université Paris-Saclay
- Université Paris-Sud
- CNRS
| | - L. J. Charbonnière
- Institut Pluridisciplinaire Hubert Curien (IPHC)
- UMR 7178 CNRS/Université de Strasbourg
- Laboratoire d’Ingénierie Moléculaire Appliquée à l’Analyse (LIMAA)
- ECPM
- 67087 Strasbourg Cedex 2
| | - P. Reiss
- Univ. Grenoble Alpes
- INAC-SyMMES
- 38054 Grenoble Cedex 9
- France
- CEA
| | - N. Hildebrandt
- NanoBioPhotonics (nanofret.com)
- Institute for Integrative Biology of the Cell (I2BC)
- Université Paris-Saclay
- Université Paris-Sud
- CNRS
| |
Collapse
|
212
|
Dong RH, Qin CC, Qiu X, Yan X, Yu M, Cui L, Zhou Y, Zhang HD, Jiang XY, Long YZ. In situ precision electrospinning as an effective delivery technique for cyanoacrylate medical glue with high efficiency and low toxicity. Nanoscale 2015; 7:19468-75. [PMID: 26531687 DOI: 10.1039/c5nr05786h] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The side effects or toxicity of cyanoacrylate used in vivo have been argued since its first application in wound closure. We propose an airflow-assisted in situ precision electrospinning apparatus as an applicator and make a detailed comparison with traditional spraying via in vitro and in vivo experiments. This novel method can not only improve operational performance and safety by precisely depositing cyanoacrylate fibers onto a wound, but significantly reduce the dosage of cyanoacrylate by almost 80%. A white blood cell count, liver function test and histological analysis prove that the in situ precision electrospinning applicator produces a better postoperative outcome, e.g., minor hepatocyte injury, moderate inflammation and the significant ability for liver regeneration. This in situ precision electrospinning method may thus dramatically broaden both civilian and military applications of cyanoacrylates.
Collapse
Affiliation(s)
- R H Dong
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - C C Qin
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - X Qiu
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - X Yan
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - M Yu
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China. and Department of Mechanical Engineering, Columbia University, New York 10027, USA
| | - L Cui
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - Y Zhou
- Medical College, Qingdao University, Qingdao 266071, P. R. China.
| | - H D Zhang
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China.
| | - X Y Jiang
- Laboratory for Biological Effects of Nanomaterials & Nanosafety, National Center for Nanoscience & Technology, Beijing 100190, P. R. China.
| | - Y Z Long
- Collaborative Innovation Center for Low-Dimensional Nanomaterials & Optoelectronic Devices, College of Physics, Qingdao University, Qingdao 266071, P. R. China. and Collaborative Innovation Center for Marine Biomass Fibers, Materials and Textiles of Shandong Province, Qingdao University, Qingdao 266071, P. R. China
| |
Collapse
|
213
|
Xu C, Ji L, Jia J, Qiu X, Luan Z, Bai Y, Zhang J, Wang H. [Causes analysis of misdiagnosis in patients with familial nasal bleeding]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2015; 29:2026-2030. [PMID: 27101670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
OBJECTIVE To analyze the causes of misdiagnosis in patients with familial nasal bleeding and to improve the level of diagnosis and treatment. METHOD The clinical characteristics of 7 families with nose blood were analyzed retrospectively and 2 typical cases were reported, including their treatment and misdiagnosis in consulting, out-patient and in-patient. RESULT Typical case 1 was misdiagnosed and mistreated for 42 years, misdiagnosed as blood disease so that the patient was biopsied in bone marrow, misdiagnosed as endometriosis so that the patient was performed uterus resection. Typical case 2 was misdiagnosed and mistreated for 17 years, misdiagnosed as upper digestive tract hemorrhage so that the patient was performed endoscopic sleeve ligation, misdiagnosed as inferior turbinate hemangioma so that the patient was performed nasal endoscopic surgery. CONCLUSION Neglect of family history and the typical signs are the causes of misdiagnosis. So asking about the family history and checking for the typical signs in patients with nose blood can avoid misdiagnosis.
Collapse
|
214
|
Liu D, Yuan Y, Li M, Qiu X. Effects of dietary quercetin on performance and cytochrome P450 expression of the cotton bollworm, Helicoverpa armigera. Bull Entomol Res 2015; 105:771-7. [PMID: 26440448 DOI: 10.1017/s0007485315000760] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Quercetin is ubiquitous in terrestrial plants. The cotton bollworm Helicoverpa armigera as a highly polyphagous insect has caused severe crop losses. Until now, interactions between this pest and quercetin are poorly understood at the biochemical and molecular levels. In this study, we investigated the in vivo effects of quercetin on performance of cotton bollworm and on cytochrome P450 (P450) expression. Deleterious effects of quercetin on the performance of the cotton bollworm, including growth, survival, pupation and adult emergence were observed after oral administration of 3 and 10 mg g(-1) quercetin to larvae since the third instar, whereas no significant toxic effect was found at 0.1 mg g(-1) quercetin treatment. Piperonyl butoxide treatment enhanced the toxicity of quercetin. In vitro metabolism studies showed that quercetin was rapidly transformed by gut enzymes of fifth instar larvae of the cotton bollworm. qRT-PCR results revealed that the effect of quercetin on P450 expression was tissue- and dose-specific. Quercetin regulated P450 expression in a mild manner, and it could serve as P450 inducer (CYP337B1, CYP6B6) or repressor (CYP337B1, CYP6B7, CYP6B27, CYP9A14, CYP6AE11, and CYP4M7). These findings are important for advancing our understanding of the biochemical and molecular response of insects to plant toxins and have implications for a smart pest control.
Collapse
Affiliation(s)
- D Liu
- State Key Laboratory of Integrated Management of Pest Insects and Rodents,Institute of Zoology, Chinese Academy of Sciences,Beijing 100101,China
| | - Y Yuan
- State Key Laboratory of Integrated Management of Pest Insects and Rodents,Institute of Zoology, Chinese Academy of Sciences,Beijing 100101,China
| | - M Li
- State Key Laboratory of Integrated Management of Pest Insects and Rodents,Institute of Zoology, Chinese Academy of Sciences,Beijing 100101,China
| | - X Qiu
- State Key Laboratory of Integrated Management of Pest Insects and Rodents,Institute of Zoology, Chinese Academy of Sciences,Beijing 100101,China
| |
Collapse
|
215
|
Shen H, Liu T, Jiang H, Titsch C, Taylor K, Kandoussi H, Qiu X, Chen C, Sukrutharaj S, Kuit K, Mintier G, Krishnamurthy P, Fancher RM, Zeng J, Rodrigues AD, Marathe P, Lai Y. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation. Drug Metab Dispos 2015; 44:238-49. [DOI: 10.1124/dmd.115.066852] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2015] [Accepted: 11/19/2015] [Indexed: 01/12/2023] Open
|
216
|
Zhang YW, Long E, Mihovilovič M, Jin G, Allada K, Anderson B, Annand JRM, Averett T, Ayerbe-Gayoso C, Boeglin W, Bradshaw P, Camsonne A, Canan M, Cates GD, Chen C, Chen JP, Chudakov E, De Leo R, Deng X, Deur A, Dutta C, El Fassi L, Flay D, Frullani S, Garibaldi F, Gao H, Gilad S, Gilman R, Glamazdin O, Golge S, Gomez J, Hansen O, Higinbotham DW, Holmstrom T, Huang J, Ibrahim H, de Jager CW, Jensen E, Jiang X, St John J, Jones M, Kang H, Katich J, Khanal HP, King P, Korsch W, LeRose J, Lindgren R, Lu HJ, Luo W, Markowitz P, Meziane M, Michaels R, Moffit B, Monaghan P, Muangma N, Nanda S, Norum BE, Pan K, Parno D, Piasetzky E, Posik M, Punjabi V, Puckett AJR, Qian X, Qiang Y, Qiu X, Riordan S, Ron G, Saha A, Sawatzky B, Schiavilla R, Schoenrock B, Shabestari M, Shahinyan A, Širca S, Subedi R, Sulkosky V, Tobias WA, Tireman W, Urciuoli GM, Wang D, Wang K, Wang Y, Watson J, Wojtsekhowski B, Ye Z, Zhan X, Zhang Y, Zheng X, Zhao B, Zhu L. Measurement of the Target-Normal Single-Spin Asymmetry in Quasielastic Scattering from the Reaction (3)He(↑)(e,e'). Phys Rev Lett 2015; 115:172502. [PMID: 26551107 DOI: 10.1103/physrevlett.115.172502] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2015] [Indexed: 06/05/2023]
Abstract
We report the first measurement of the target single-spin asymmetry, A(y), in quasielastic scattering from the inclusive reaction (3)He(↑)(e,e') on a (3)He gas target polarized normal to the lepton scattering plane. Assuming time-reversal invariance, this asymmetry is strictly zero for one-photon exchange. A nonzero A(y) can arise from the interference between the one- and two-photon exchange processes which is sensitive to the details of the substructure of the nucleon. An experiment recently completed at Jefferson Lab yielded asymmetries with high statistical precision at Q(2)=0.13, 0.46, and 0.97 GeV(2). These measurements demonstrate, for the first time, that the (3)He asymmetry is clearly nonzero and negative at the 4σ-9σ level. Using measured proton-to-(3)He cross-section ratios and the effective polarization approximation, neutron asymmetries of -(1-3)% were obtained. The neutron asymmetry at high Q(2) is related to moments of the generalized parton distributions (GPDs). Our measured neutron asymmetry at Q(2)=0.97 GeV(2) agrees well with a prediction based on two-photon exchange using a GPD model and thus provides a new, independent constraint on these distributions.
Collapse
Affiliation(s)
- Y-W Zhang
- Rutgers University, New Brunswick, New Jersey 08901, USA
- University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - E Long
- Kent State University, Kent, Ohio 44242, USA
| | | | - G Jin
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Allada
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Anderson
- Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- Glasgow University, Glasgow G12 8QQ Scotland, United Kingdom
| | - T Averett
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - C Ayerbe-Gayoso
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33181, USA
| | - P Bradshaw
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Canan
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - G D Cates
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - C Chen
- Hampton University, Hampton, Virginia 23669, USA
| | - J P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Chudakov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R De Leo
- Università degli studi di Bari Aldo Moro, I-70121 Bari, Italy
| | - X Deng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Dutta
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - L El Fassi
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - D Flay
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Frullani
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - F Garibaldi
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - H Gao
- Duke University, Durham, North Carolina 27708, USA
| | - S Gilad
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Gilman
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - O Glamazdin
- Kharkov Institute of Physics and Technology, Kharkov 61108, Ukraine
| | - S Golge
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D W Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Holmstrom
- Longwood University, Farmville, Virginia 23909, USA
| | - J Huang
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - H Ibrahim
- Cairo University, Cairo, Giza 12613, Egypt
| | - C W de Jager
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Jensen
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - X Jiang
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - J St John
- Longwood University, Farmville, Virginia 23909, USA
| | - M Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Kang
- Seoul National University, Seoul 151-742, Korea
| | - J Katich
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - H P Khanal
- Florida International University, Miami, Florida 33181, USA
| | - P King
- Ohio University, Athens, Ohio 45701, USA
| | - W Korsch
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - J LeRose
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Lindgren
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - H-J Lu
- Huangshan University, Tunxi, Huangshan City, Anhui Province 245041, People's Republic of China
| | - W Luo
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - P Markowitz
- Florida International University, Miami, Florida 33181, USA
| | - M Meziane
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Moffit
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Monaghan
- Hampton University, Hampton, Virginia 23669, USA
| | - N Muangma
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Nanda
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B E Norum
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Pan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D Parno
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | | | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - V Punjabi
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - A J R Puckett
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - X Qian
- Duke University, Durham, North Carolina 27708, USA
| | - Y Qiang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - X Qiu
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - S Riordan
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - G Ron
- Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - A Saha
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Sawatzky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Schiavilla
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B Schoenrock
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - M Shabestari
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - A Shahinyan
- Yerevan Physics Institute, Yerevan 375036, Armenia
| | - S Širca
- Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia
- University of Ljubljana, SI-1000 Ljubljana, Slovenia
| | - R Subedi
- George Washington University, Washington, D.C. 20052, USA
| | - V Sulkosky
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - W A Tobias
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - W Tireman
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - G M Urciuoli
- Istituto Nazionale Di Fisica Nucleare, INFN/Sanita, 00161 Roma, Italy
| | - D Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - K Wang
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - Y Wang
- University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA
| | - J Watson
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Ye
- Hampton University, Hampton, Virginia 23669, USA
| | - X Zhan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Y Zhang
- Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22908, USA
| | - B Zhao
- The College of William and Mary, Williamsburg, Virginia 23187, USA
| | - L Zhu
- Hampton University, Hampton, Virginia 23669, USA
| |
Collapse
|
217
|
Eng L, Qiu X, Su J, Brown MC, Irwin M, Pringle D, Naik H, Niu C, Mahler M, Hon H, Tiessen K, Charow R, Thai H, Ho V, Pat V, Herzog L, Ho A, Jones JM, Howell D, Goldstein DP, Giuliani ME, Xu W, Selby P, Liu G. Abstract B15: Second-hand smoke (SHS) and smoking cessation in non-tobacco related cancers. Cancer Prev Res (Phila) 2015. [DOI: 10.1158/1940-6215.prev-14-b15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Continued smoking after a diagnosis of cancer has been found to lead to poorer treatment response, reduced survival and quality of life and increased risk of second primary cancers. We have previously demonstrated that SHS (exposure at home, with spouses and peers) is a significant barrier to smoking cessation in tobacco-related (lung and head and neck) cancers with adjust odds ratios of 6-9 (PMID: 24419133, 23765604) for quitting 1 year after diagnosis and quitting at any time after diagnosis; relationships stronger than in non-cancer populations. Here, we examined whether this relationship exists in cancers that are not traditionally associated with smoking.
Patients and Methods: Cancer survivors from a single tertiary cancer centre, Princess Margaret Cancer Centre (Toronto, Canada) completed a one-time cross-sectional questionnaire assessing their socio-demographics, functional status, smoking history and SHS exposure. Clinico-pathological variables were obtained through review of patient charts. Multivariate logistic regression and Cox-proportional hazard models evaluated the association of SHS with smoking cessation at 1 year after diagnosis and any time after diagnosis, and time-to-quitting respectively, adjusted for significant co-variates.
Results: A total of 1011 non-tobacco related cancer survivors were surveyed between 2012 and 2014: 19% breast, 15% gastrointestinal, 16% genitourinary, 12% gynecological, 23% hematologic, 15% other. Median follow-up time after diagnosis was 26 months. Among the 162 patients currently smoking at diagnosis, 35% quit 1 year after diagnosis and 48% quit at any time after diagnosis. None of the 306 ex-smokers and 543 never smokers (re-)started smoking after diagnosis. Home exposure to SHS was found to be strongly associated with reduced smoking cessation in cancer patients at any time after diagnosis (aOR=4.28, 95% CI (1.56-11.78), P=4.8E-3), while there was a less strong and non-significant trend for home exposure to SHS and reduced smoking cessation at 1 year after diagnosis (aOR=2.56, 95% CI (0.91-7.22), P=0.08)). Time-to-quitting analysis for home exposure to SHS were consistent with these results (aHR=2.76, 95% CI (1.15-6.59), P=0.02)). Unlike lung and head and neck cancer patients, spousal and peer smoking were not found significantly associated with smoking cessation at either time-point (P>0.05). Kaplan-Meier analysis found that 72% of patients who quit, did so within 1 year of their cancer diagnosis. When comparing factors between patients quitting one year after diagnosis versus quitting more than one year after diagnosis, those quitting at one year were more likely older (P<0.05) and have received surgery as part of their cancer care (P=0.06).
Conclusions: Home exposure to SHS is a significant barrier to quitting smoking after a diagnosis of cancer in both tobacco-related and non-tobacco related cancers; while spousal and peer smoking were not found significantly associated with smoking cessation in non-tobacco related cancers. Unlike in tobacco-related cancers, home exposure to SHS had a weaker association with quitting at 1 year after diagnosis than quitting at any time after diagnosis; suggesting the effect of the “teachable moment” with SHS and cancer may not be as strong in these cancers. Survivorship programs focusing on secondary prevention and smoking cessation in cancer patients should focus on incorporating SHS exposure.
Citation Format: Lawson Eng, Xin Qiu, Jie Su, M Catherine Brown, Margaret Irwin, Dan Pringle, Hiten Naik, Chongya Niu, Mary Mahler, Henrique Hon, Kyoko Tiessen, Rebecca Charow, Henry Thai, Valerie Ho, Vivien Pat, Lindsay Herzog, Anthea Ho, Jennifer M. Jones, Doris Howell, David P. Goldstein, Meredith E. Giuliani, Wei Xu, Peter Selby, Geoffrey Liu. Second-hand smoke (SHS) and smoking cessation in non-tobacco related cancers. [abstract]. In: Proceedings of the Thirteenth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2014 Sep 27-Oct 1; New Orleans, LA. Philadelphia (PA): AACR; Can Prev Res 2015;8(10 Suppl): Abstract nr B15.
Collapse
Affiliation(s)
- Lawson Eng
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Xin Qiu
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Jie Su
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | | | | | - Dan Pringle
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Hiten Naik
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Chongya Niu
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Mary Mahler
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Henrique Hon
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Kyoko Tiessen
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | | | - Henry Thai
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Valerie Ho
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Vivien Pat
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | | | - Anthea Ho
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | | | - Doris Howell
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | | | | | - Wei Xu
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| | - Peter Selby
- 2Centre for Addiction and Mental Health, Toronto, ON, Canada
| | - Geoffrey Liu
- 1Princess Margaret Cancer Centre, Toronto, ON, Canada,
| |
Collapse
|
218
|
Qiu X, Cheng JC, Klausen C, Chang HM, Fan Q, Leung PCK. EGF-Induced Connexin43 Negatively Regulates Cell Proliferation in Human Ovarian Cancer. J Cell Physiol 2015; 231:111-9. [DOI: 10.1002/jcp.25058] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2014] [Accepted: 05/26/2015] [Indexed: 12/13/2022]
Affiliation(s)
- Xin Qiu
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| | - Jung-Chien Cheng
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| | - Christian Klausen
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| | - Hsun-Ming Chang
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| | - Qianlan Fan
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| | - Peter C. K. Leung
- Department of Obstetrics and Gynaecology; Child & Family Research Institute; University of British Columbia; Vancouver British Columbia Canada
| |
Collapse
|
219
|
Adamson P, Anghel I, Ashby N, Aurisano A, Barr G, Bishai M, Blake A, Bock G, Bogert D, Bumgarner R, Cao S, Castromonte C, Childress S, Coelho J, Corwin L, Cronin-Hennessy D, de Jong J, Devan A, Devenish N, Diwan M, Escobar C, Evans J, Falk E, Feldman G, Fonville B, Frohne M, Gallagher H, Gomes R, Goodman M, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn S, Hartnell J, Hatcher R, Hirschauer J, Holin A, Huang J, Hylen J, Irwin G, Isvan Z, James C, Jefferts S, Jensen D, Kafka T, Kasahara S, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield P, Lucas P, Mann W, Marshak M, Matsakis D, Mayer N, McKinley A, McGivern C, Medeiros M, Mehdiyev R, Meier J, Messier M, Miller W, Mishra S, Mitchell S, Moed Sher S, Moore C, Mualem L, Musser J, Naples D, Nelson J, Newman H, Nichol R, Nowak J, O’Connor J, Orchanian M, Pahlka R, Paley J, Parker T, Patterson R, Pawloski G, Perch A, Phan-Budd S, Plunkett R, Poonthottathil N, Powers E, Qiu X, Radovic A, Rebel B, Ridl K, Römisch S, Rosenfeld C, Rubin H, Sanchez M, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga R, Thomas J, Thomson M, Tian X, Timmons A, Tognini S, Toner R, Torretta D, Urheim J, Vahle P, Viren B, Weber A, Webb R, White C, Whitehead L, Whitehead L, Wojcicki S, Wright J, Zhang V, Zwaska R. Precision measurement of the speed of propagation of neutrinos using the MINOS detectors. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.92.052005] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
220
|
Tang Y, Ye M, Du Y, Qiu X, Lv X, Yang W, Luo J. EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neuroscience 2015. [PMID: 26204818 DOI: 10.1016/j.neuroscience.2015.07.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
N-methyl-d-aspartate receptors (NMDARs) have been known to be regulated by various receptor tyrosine kinases. Activation of epidermal growth factor receptor (EGFR) specifically increases NMDAR-mediated currents and enhances long-term potentiation (LTP) in the hippocampus. However, the mechanism through which EGFR regulates NMDARs remains to be elucidated. In this study we found that EGFR was highly expressed in the hippocampus and mainly localized in the non-synaptic region including the soma and neurites of cultured hippocampal neurons. EGFR activation led to an increase in ifenprodil-sensitive NMDAR currents. Consistent with this, we also observed that surface expression of GluN2B-containing NMDAR was upregulated. Our biochemical data from hippocampal slices and hippocampal cultured neurons demonstrated that EGF treatment in vitro significantly increased phosphorylation of the GluN2B subunit at Y1472 with a coincidental activation of Src family kinases (SFKs). EGFR blockade with a specific antagonist BIBX-1382 attenuated an increase of GluN2B in the postsynaptic density during high-frequency stimulation (HFS)-induced LTP. Moreover, BIBX blockade significantly impaired HFS-induced LTP. In conclusion, our findings suggest that EGFR signaling upregulates NMDARs through modification of the GluN2B subunit, and is required for HFS-induced LTP in the hippocampus.
Collapse
Affiliation(s)
- Y Tang
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - M Ye
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - Y Du
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - X Qiu
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - X Lv
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - W Yang
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China
| | - J Luo
- Department of Neurobiology, Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
| |
Collapse
|
221
|
Qiu X, Cheng JC, Zhao J, Chang HM, Leung PCK. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling. Cell Signal 2015; 27:1956-62. [PMID: 26186970 DOI: 10.1016/j.cellsig.2015.07.010] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2015] [Accepted: 07/13/2015] [Indexed: 11/24/2022]
Abstract
Reduced connexin43 (Cx43) expression is frequently detected in different types of human cancer. Cx43 has been shown to regulate cancer cell migration in a cell-type dependent manner. In both primary and recurrent human ovarian cancer, overexpression of TGF-β ligand and its receptors have been detected. TGF-β can regulate Cx43 expression in other cell types and stimulate human ovarian cancer cell migration. However, whether Cx43 can be regulated by TGF-β and is involved in TGF-β-stimulated cell migration in human ovarian cancer cells remain unknown. In this study, we demonstrate that TGF-β up-regulates Cx43 in two human ovarian cancer cell lines, SKOV3 and OVCAR4. The stimulatory effect of TGF-β on Cx43 expression is blocked by inhibition of TGF-β receptor. Treatment with TGF-β activates Smad2 and Smad3 signaling pathways in both ovarian cancer cell lines. In addition, siRNA-mediated knockdown of Smad2 or Smd3 abolishes TGF-β-induced up-regulation of Cx43 expression. Moreover, knockdown of Cx43 attenuates TGF-β-stimulated cell migration. This study demonstrates an important role for Cx43 in mediating the effects of TGF-β on human ovarian cancer cell migration.
Collapse
Affiliation(s)
- Xin Qiu
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Jung-Chien Cheng
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Jianfang Zhao
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Hsun-Ming Chang
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Peter C K Leung
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
| |
Collapse
|
222
|
Niu C, Eng L, Qiu X, Shen X, Espin-Garcia O, Song Y, Pringle D, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K, Brown MC, Selby P, Howell D, Jones JM, Xu W, Liu G, Alibhai SMH. Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors. J Oncol Pract 2015; 11:e450-9. [PMID: 26060227 DOI: 10.1200/jop.2014.002287] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE Improved cancer screening and treatment have led to a greater focus on cancer survivorship care. Older cancer survivors may be a unique population. We evaluated whether older cancer survivors (age ≥ 65 years) had lifestyle behaviors, attitudes, and knowledge distinct from younger survivors. PATIENTS AND METHODS Adult cancer survivors with diverse cancer subtypes were recruited from Princess Margaret Cancer Centre (Toronto, Ontario, Canada). Multivariable models evaluated the effect of age on smoking, alcohol, and physical activity habits, attitudes toward and knowledge of these habits on cancer outcomes, and lifestyle information and recommendations received from health care providers, adjusted for sociodemographic and clinicopathologic covariates. RESULTS Among the 616 survivors recruited, 23% (n = 139) were older. Median follow-up since diagnosis was 24 months. Older survivors were more likely ex-smokers and less likely current smokers than younger survivors, but they were less likely to know that smoking could affect cancer treatment (adjusted odds ratio [OR], 0.53; P = .007) or prognosis (adjusted OR, 0.53; P = .008). Older survivors were more likely to perceive alcohol as improving overall survival (adjusted OR, 2.39; P = .02). Rates of meeting moderate-to-vigorous physical activity guidelines 1 year before diagnosis (adjusted OR, 0.55; P = .02) and maintaining and improving their exercise levels to meet these guidelines after diagnosis (adjusted OR, 0.48; P = .02) were lower in older survivors. Older and younger cancer survivors reported similar rates of receiving lifestyle behavior information from health care providers (P = .36 to .98). CONCLUSION Older cancer survivors reported being less aware of the impact of smoking on their overall health, more likely perceived alcohol as beneficial to survival, and were less likely to meet exercise goals compared with younger survivors. Survivorship programs need to consider age when counseling on lifestyle behaviors.
Collapse
Affiliation(s)
- Chongya Niu
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Lawson Eng
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Xin Qiu
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Xiaowei Shen
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Osvaldo Espin-Garcia
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Yuyao Song
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Dan Pringle
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Mary Mahler
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Oleksandr Halytskyy
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Rebecca Charow
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Christine Lam
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Ravi M Shani
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Jodie Villeneuve
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Kyoko Tiessen
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - M Catherine Brown
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Peter Selby
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Doris Howell
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Jennifer M Jones
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Wei Xu
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Geoffrey Liu
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| | - Shabbir M H Alibhai
- Princess Margaret Cancer Centre/University Health Network; University of Toronto; Ontario Cancer Institute; Toronto General Hospital/University Health Network; and Centre for Addiction and Mental Health, Toronto, Ontario, Canada
| |
Collapse
|
223
|
Qiu X, Voros L, Cohen G, Mageras G, Yang J, Zaider M. TH-AB-BRA-01: Biologically Based Prostate Cancer Treatment Planning with Combined Brachytherapy and External Beam Radiotherapy. Med Phys 2015. [DOI: 10.1118/1.4926144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
224
|
Eng L, Azad AK, Qiu X, Kong QQ, Cheng D, Ying N, Tse A, Kuang Q, Dodbiba L, Renouf DJ, Marsh S, Savas S, Mackay HJ, Knox JJ, Darling GE, Wong RK, Xu W, Liu G, Faluyi OO. Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis 2015; 36:956-62. [DOI: 10.1093/carcin/bgv073] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2014] [Accepted: 05/20/2015] [Indexed: 01/13/2023] Open
|
225
|
Naik H, Howell D, Su J, Qiu X, Brown C, Vennettilli A, Irwin M, Pat V, Solomon H, Wang T, Hon H, Eng L, Mahler M, Thai H, Ho V, Xu W, Seung SJ, Mittmann N, Liu G. Stage specific health utility index scores of Canadian cancer patients. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.6614] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Hiten Naik
- University of Toronto, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Jie Su
- Princess Margaret Hospital, Toronto, ON, Canada
| | - Xin Qiu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Catherine Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Ashlee Vennettilli
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Margaret Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Vivien Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Hannah Solomon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Tian Wang
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henrique Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lawson Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Mary Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henry Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Valerie Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Department of Biostatistic, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Soo Jin Seung
- HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - Nicole Mittmann
- HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
226
|
Bao S, Yu S, Guo X, Zhang F, Sun Y, Tan L, Duan Y, Lu F, Qiu X, Ding C. Construction of a cell-surface display system based on the N-terminal domain of ice nucleation protein and its application in identification of mycoplasma
adhesion proteins. J Appl Microbiol 2015; 119:236-44. [DOI: 10.1111/jam.12824] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2014] [Revised: 03/30/2015] [Accepted: 03/31/2015] [Indexed: 11/30/2022]
Affiliation(s)
- S. Bao
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
- College of Veterinary Medicine; Gansu Agricultural University; Lanzhou China
| | - S. Yu
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - X. Guo
- College of Veterinary Medicine; Gansu Agricultural University; Lanzhou China
| | - F. Zhang
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - Y. Sun
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - L. Tan
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - Y. Duan
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - F. Lu
- College of Veterinary Medicine; Gansu Agricultural University; Lanzhou China
| | - X. Qiu
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| | - C. Ding
- Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Shanghai China
| |
Collapse
|
227
|
Eng L, Qiu X, Su J, Pringle D, Niu C, Mahler M, Charow R, Villeneuve J, Halytskyy O, Lam C, Tiessen K, Brown MC, Howell D, Giuliani ME, Jones JM, Alibhai SMH, Goldstein DP, Xu W, Selby P, Liu G. The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers. Cancer 2015; 121:2655-63. [DOI: 10.1002/cncr.29340] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Revised: 02/07/2015] [Accepted: 02/10/2015] [Indexed: 11/10/2022]
Affiliation(s)
- Lawson Eng
- Division of Medical Oncology and Hematology; Department of Medicine; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
- Ontario Cancer Institute; Toronto Ontario Canada
- Department of Medicine; University Health Network; Toronto Ontario Canada
| | - Xin Qiu
- Department of Biostatistics; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
| | - Jie Su
- Department of Biostatistics; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
| | - Dan Pringle
- Ontario Cancer Institute; Toronto Ontario Canada
| | - Chongya Niu
- Division of Medical Oncology and Hematology; Department of Medicine; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
- Ontario Cancer Institute; Toronto Ontario Canada
| | - Mary Mahler
- Ontario Cancer Institute; Toronto Ontario Canada
| | | | | | | | | | | | | | - Doris Howell
- Division of Medical Oncology and Hematology; Department of Medicine; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
- Ontario Cancer Institute; Toronto Ontario Canada
| | - Meredith E. Giuliani
- Ontario Cancer Institute; Toronto Ontario Canada
- Department of Radiation Oncology; Princess Margaret Cancer Centre; Toronto Ontario Canada
| | | | | | - David P. Goldstein
- Department of Otolaryngology-Head and Neck Surgery; University of Toronto, University Health Network; Toronto Ontario Canada
| | - Wei Xu
- Department of Biostatistics; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
- Dalla Lana School of Public Health, University of Toronto; Toronto Ontario Canada
| | - Peter Selby
- Centre for Addiction and Mental Health; University of Toronto; Toronto Ontario Canada
- Department of Family and Community Medicine; University of Toronto; Toronto Ontario Canada
- Department of Psychiatry; University of Toronto; Toronto Ontario Canada
| | - Geoffrey Liu
- Division of Medical Oncology and Hematology; Department of Medicine; Princess Margaret Cancer Centre/University Health Network and University of Toronto; Toronto Ontario Canada
- Ontario Cancer Institute; Toronto Ontario Canada
- Department of Medicine; University Health Network; Toronto Ontario Canada
- Dalla Lana School of Public Health, University of Toronto; Toronto Ontario Canada
| |
Collapse
|
228
|
Qiu X, Cheng JC, Klausen C, Fan Q, Chang HM, So WK, Leung PCK. Transforming growth factor-α induces human ovarian cancer cell invasion by down-regulating E-cadherin in a Snail-independent manner. Biochem Biophys Res Commun 2015; 461:128-35. [PMID: 25869072 DOI: 10.1016/j.bbrc.2015.03.180] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Accepted: 03/31/2015] [Indexed: 01/22/2023]
Abstract
Transforming growth factor-α (TGF-α), like epidermal growth factor (EGF) and amphiregulin (AREG) binds exclusively to EGF receptor (EGFR). We have previously demonstrated that EGF, AREG and TGF-α down-regulate E-cadherin and induce ovarian cancer cell invasion, though whether these ligands use the same molecular mediators remains unknown. We now show that, like EGF, TGF-α- and AREG-induced E-cadherin down-regulation involves both EGFR and HER2. However, in contrast to EGF and AREG, the transcription factor Snail is not required for TGF-α-induced E-cadherin down-regulation. This study shows that TGF-α uses common and divergent molecular mediators to regulate E-cadherin expression and cell invasion.
Collapse
Affiliation(s)
- Xin Qiu
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Jung-Chien Cheng
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Christian Klausen
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Qianlan Fan
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Hsun-Ming Chang
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Wai-Kin So
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Peter C K Leung
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
| |
Collapse
|
229
|
Abstract
CONTEXT Theca cell-derived bone morphogenetic protein 4 (BMP4) and BMP7 are important regulators of folliculogenesis and have been shown to inhibit luteinization. Pentraxin 3 (PTX3) plays a critical role in the assembly of the cumulus oophorus extracellular matrix, which is essential for cumulus expansion during ovulation and may be modulated by BMP4 and BMP7. OBJECTIVE The aim of this study was to investigate the effects of BMP4 and BMP7 on the expression of PTX3 in human granulosa cells and to examine their underlying molecular determinants. DESIGN An established immortalized human granulosa cell line (SVOG), a granulosa cell tumor cell line (KGN), and primary granulosa-lutein cells were used as study models. PTX3 expression and accumulation as well as Smad1/5/8 phosphorylation were examined after exposure to recombinant human BMP4 and BMP7. BMP type I receptor involvement was investigated with inhibitors (dorsomorphin and DMH-1 (4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline)) and small interfering RNAs targeting activin receptor-like kinase (ALK)2, ALK3, and/or ALK6. Small interfering RNAs targeting Smad4 were used to verify the involvement of Smad signaling. SETTING The study was conducted at an academic research center. MAIN OUTCOME MEASURES Quantitative RT-PCR and Western blot were used to measure mRNA and protein levels, respectively. Levels of PTX3 and BMP4 were measured by ELISA. RESULTS Treatment with BMP4 and BMP7 significantly decreased PTX3 mRNA and protein production. These suppressive effects, along with the induction of Smad1/5/8 phosphorylation, were attenuated by cotreatment with 2 BMP type I receptor inhibitors (dorsomorphin and/or DMH-1). Combined knockdown (ALK3/ALK6 for BMP4 and ALK2/ALK3 for BMP7) reversed the effects of BMP4- and BMP7-induced Smad1/5/8 phosphorylation and PTX3 suppression. Furthermore, Smad4 knockdown reversed the suppressive effects of BMP4 and BMP7 on PTX3 expression. In follicular fluid, concentrations of PTX3 were negatively correlated with concentrations of BMP4. CONCLUSION BMP4 and BMP7 use differential subsets of BMP type I receptors to downregulate PTX3 expression via Smad-dependent signaling in human granulosa cells.
Collapse
Affiliation(s)
- Hsun-Ming Chang
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
| | | | | | | | | | | | | |
Collapse
|
230
|
Wan Y, Bai Y, Sun S, Qiu X, Zheng Y, Wang H, Wang H. Increased expression of transcription factor Bcl-6 in chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol 2015; 273:391-9. [PMID: 25711734 DOI: 10.1007/s00405-015-3498-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Accepted: 01/03/2015] [Indexed: 02/06/2023]
Abstract
B cell activation and excessive immunoglobulin (Ig) production were suggested as the key molecular events of chronic rhinosinusitis with nasal polyp (CRSwNP). However, whether T follicular cells (Tfh cells) were involved in this process has not been documented. In this study, 22 CRSwNP patients and 12 normal controls were enrolled, Bcl-6 (the key transcription factor for Tfh cell differentiation) immunoreactivity was examined by immunohistochemical staining, and the mRNA and protein expression of Bcl-6 and IL-21 was examined using qPCR, ELISA and Western blot, respectively. Moreover, the frequencies of Bcl-6(+)CD4(+) cells (Tfh cells) in polyp tissues and normal controls were measured by flow cytometry. We found that Bcl-6 mRNA and protein levels, as well as the frequencies of Bcl-6(+)CD4(+) cells were significantly increased in polyp tissues compared with normal controls. The frequencies of Bcl-6(+)CD4(+) cells were found to be significantly associated with B cell cluster formation, tissue eosinophilia, asthma comorbidity and polyp recurrence. These findings thus added a new insight into the molecular mechanisms underlying CRSwNP and raise the possibility that Tfh cells could be a novel therapeutic target for difficult-to-treat CRSwNP.
Collapse
Affiliation(s)
- Yuzhu Wan
- Department of Otorhinolaryngology, Shandong Provincial Hospital Affiliated to Shandong University, No. 4, West Duanxin Road, Huaiyin District, Ji'nan, 250021, China
| | - Yin Bai
- Department of Otolaryngology, The PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, China
| | - Sujuan Sun
- Department of Otorhinolaryngology, Shandong Provincial Hospital Affiliated to Shandong University, No. 4, West Duanxin Road, Huaiyin District, Ji'nan, 250021, China
| | - Xin Qiu
- Department of Otolaryngology, The PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, China
| | - Yan Zheng
- Department of Otolaryngology, The Second Affiliated Hospital, Xinjiang Medical University, No. 38, East Nanhu Road, Xinjiang, 830063, China.
| | - Hongtian Wang
- Department of Otolaryngology, The PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, China.
| | - Haibo Wang
- Department of Otorhinolaryngology, Shandong Provincial Hospital Affiliated to Shandong University, No. 4, West Duanxin Road, Huaiyin District, Ji'nan, 250021, China.
| |
Collapse
|
231
|
Qiu X, Wang H. [Research progress of monoclonal antibody omalizumab in the treatment of allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2015; 50:166-168. [PMID: 25916543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
|
232
|
Adamson P, Anghel I, Aurisano A, Barr G, Bishai M, Blake A, Bock G, Bogert D, Cao S, Castromonte C, Childress S, Coelho J, Corwin L, Cronin-Hennessy D, de Jong J, Devan A, Devenish N, Diwan M, Escobar C, Evans J, Falk E, Feldman G, Frohne M, Gallagher H, Gomes R, Goodman M, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn S, Hartnell J, Hatcher R, Holin A, Huang J, Hylen J, Irwin G, Isvan Z, James C, Jensen D, Kafka T, Kasahara S, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield P, Lucas P, Mann W, Marshak M, Mayer N, McGivern C, Medeiros M, Mehdiyev R, Meier J, Messier M, Miller W, Mishra S, Moed Sher S, Moore C, Mualem L, Musser J, Naples D, Nelson J, Newman H, Nichol R, Nowak J, O’Connor J, Orchanian M, Pahlka R, Paley J, Patterson R, Pawloski G, Perch A, Pfützner M, Phan-Budd S, Plunkett R, Poonthottathil N, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin H, Sanchez M, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga R, Thomas J, Thomson M, Tian X, Timmons A, Tognini S, Toner R, Torretta D, Urheim J, Vahle P, Viren B, Walding J, Weber A, Webb R, White C, Whitehead L, Whitehead L, Wojcicki S, Zwaska R. Study of quasielastic scattering using charged-currentνμ-iron interactions in the MINOS near detector. Int J Clin Exp Med 2015. [DOI: 10.1103/physrevd.91.012005] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
233
|
Fan Q, Cheng JC, Qiu X, Chang HM, Leung PCK. EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration. Biochem Biophys Res Commun 2015; 457:256-61. [PMID: 25576358 DOI: 10.1016/j.bbrc.2014.12.097] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Accepted: 12/22/2014] [Indexed: 11/17/2022]
Abstract
Although epithelial cell adhesion molecule (EpCAM) is overexpressed in human epithelial ovarian cancer (EOC), some contradictory results have been reported regarding the correlation between EpCAM overexpression and patient survival. In addition to this controversy, the function and regulation of EpCAM in EOC remain largely unknown. Here, we show that epidermal growth factor (EGF) up-regulates EpCAM expression by activating ERK1/2 signaling in a human EOC cell line, SKOV3. Additionally, EpCAM overexpression suppresses not only basal but also EGF-stimulated SKOV3 cell migration, whereas EpCAM knockdown increases both basal and EGF-stimulated cell migration in another human EOC cell line, OVCAR4. This study demonstrates the regulation of EpCAM and its role in mediating the effects of EGF on human EOC cell migration.
Collapse
Affiliation(s)
- Qianlan Fan
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Jung-Chien Cheng
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Xin Qiu
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Hsun-Ming Chang
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Peter C K Leung
- Department of Obstetrics and Gynaecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
| |
Collapse
|
234
|
Espin-Garcia O, Shen X, Qiu X, Brhane Y, Liu G, Xu W. Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach. BMC Proc 2014; 8:S70. [PMID: 25519401 PMCID: PMC4143809 DOI: 10.1186/1753-6561-8-s1-s70] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
We propose a genetic association analysis using Dirichlet regression to analyze the Genetic Analysis Workshop 18 data. Clinical variables, arranged in a longitudinal data structure, are employed to fit a multistate transition model in which the transition probabilities are served as a response in the proposed analysis. Furthermore, a gene-based association analysis via penalized regression is implemented using the markers at a single-nucleotide polymorphism level that we previously identified via nonpenalized Dirichlet regression.
Collapse
Affiliation(s)
- Osvaldo Espin-Garcia
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave., Toronto, ON, M5G 2M9, Canada ; Department of Statistics and Actuarial Science, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada
| | - Xiaowei Shen
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave., Toronto, ON, M5G 2M9, Canada ; Department of Statistics and Actuarial Science, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada
| | - Xin Qiu
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave., Toronto, ON, M5G 2M9, Canada
| | - Yonathan Brhane
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Toronto, ON, M5T 3L9, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute/Princess Margaret Cancer Centre, 610 University Ave., Toronto, ON, M5G 2M9, Canada ; Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON M5T 3M7, Canada
| | - Wei Xu
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave., Toronto, ON, M5G 2M9, Canada ; Dalla Lana School of Public Health, University of Toronto, 155 College St., Toronto, ON M5T 3M7, Canada
| |
Collapse
|
235
|
Abstract
Novel aromatic poly(benzoxazole–imide)s containing naphthalene were prepared from synthesized 1,4-di(5-aminobenzoxazol-2-yl)naphthalene and commercial dianhydrides by conventional two-step polymerization. The polymers showed high levels of tensile strength of up to 294 MPa and modulus of up to 6.5 GPa. The glass transition temperatures of the polymers were observed between 267°C and 345°C. The 5% weight loss temperatures of the polymers were tested in the range of 517–562°C in nitrogen atmosphere. The excellent properties of polymers were attributed to their rigid-rod-like molecular structure. The polymers emitted different fluorescence with maximum emission wavelengths in the range of 470–560 nm. Increasing the dianhydride electron affinity, the emission spectra peak value of polyimides (PIs) except PI6 increased gradually, but the fluorescent intensity of the PIs decreased. The 1,4-bis(3,4-dicarboxyphenoxy)benzene dianhydride-derived PI film exhibit highly fluorescent characteristics; however, the PI film from pyromellitic dianhydride was nonfluorescent.
Collapse
Affiliation(s)
- X. Ma
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - X. Ma
- CAST-Xi’an Institute of Space Radio Technology, China Academy of Space Technology, Xi’an, China
| | - X. Qiu
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - R. Jin
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - C. Kang
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - L. Gao
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| |
Collapse
|
236
|
Subedi K, Yu HM, Newell M, Weselake RJ, Meesapyodsuk D, Qiu X, Shah S, Field CJ. Stearidonic acid-enriched flax oil reduces the growth of human breast cancer in vitro and in vivo. Breast Cancer Res Treat 2014; 149:17-29. [DOI: 10.1007/s10549-014-3212-3] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2014] [Accepted: 11/14/2014] [Indexed: 12/24/2022]
|
237
|
Naik H, Howell D, Qiu X, Brown C, Vennettilli A, Irwin M, Pat V, Solomon H, Wang T, Hon H, Eng L, Mahler M, Tiessen K, Thai H, Ho V, Pringle D, Xu W, Seung SJ, Mittmann N, Liu G. Canadian cancer site-specific health utility values: Creating the basis for measuring value and costs of therapy. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.30_suppl.7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7 Background: Health utility values (HUVs) play an integral role when conducting health economic analyses, but a paucity of reference HUVs exists for cancer patients. Using EQ-5D, we generated reference HUVs for multiple malignancies. We further assessed patient willingness to compete the instrument on a regular basis by adding the EQ-5D to an Ontario-wide patient-reported symptom tool mandated by Cancer Care Ontario, the provincial cancer government agency. Methods: 1,831 cancer patients across all non-CNS solid and hematologic cancer sites at the Princess Margaret Cancer Centre completed the EQ-5D instrument; a subset (n=618) were asked about the acceptability of regularly completing the EQ-5D. HUVs were calculated using Canadian valuations. Results: The mean±SD HUV for all patients was 0.81±0.15, but were significantly different across different disease sites (p<0.0001): Testicular cancer, 0.87±0.13; prostate, 0.87±0.15; colorectal, 0.83±0.12; head/neck, 0.82±0.15; lymphoma, 0.82±0.15; breast, 0.81±0.17; esophageal, 0.81±0.16; ovarian, 0.79±0.15; leukemia, 0.78±0.15; lung, 0.78±0.13 and myeloma, 0.77±0.14. Confirming the validity of these HUVs, patients with PRO-ECOG scores of 0, 1, 2 and 3 had HUVs of 0.90±0.14, 0.77±0.11, 0.65±0.14 and 0.59±0.19, respectively (p<0.0001). In patients with solid tumors, those with local disease had HUVs of 0.82±0.15; metastatic disease, 0.80±0.15; p=0.015. 88% of patients reported that the EQ-5D was easy to complete, 92% took less than 5 minutes, 89% were satisfied with its length and 86% were satisfied with the types of questions asked. Importantly, 92% reported that they would complete the EQ-5D, even if it was used solely for research purposes and 73% agreed with the notion of completing it regularly at their clinic visits. Conclusions: We present the first Canadian reference dataset of HUVs for common cancers; stage-and site-specific reference values will be presented at the meeting. Mean HUVs varied by disease site, performance status, and disease severity. Furthermore, a majority of patients surveyed were willing to complete the EQ-5D on a regular basis, suggesting that routine administration is feasible across Ontario.
Collapse
Affiliation(s)
- Hiten Naik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Xin Qiu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Catherine Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Ashlee Vennettilli
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Margaret Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Vivien Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Hannah Solomon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Tian Wang
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henrique Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lawson Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Mary Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Kyoko Tiessen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henry Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Valerie Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Dan Pringle
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Soo Jin Seung
- HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - Nicole Mittmann
- HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
238
|
Naik H, Liu G, Qiu X, Pringle D, Brown C, Eng L, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Jones JM, Xu W, Howell D. Effect of physical activity (PA) perceptions in cancer survivors on PA behaviors: Helping health care providers improve patient communication. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.30_suppl.201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
201 Background: While engagement in PA can lessen fatigue, improve quality of life (QOL) and/or improve survival in cancer survivors, to what extent patients are aware of this and how it affects their behavior is unclear. Methods: 1,244 adult cancer survivors across disease sites and stages (mostly curative) at the Princess Margaret Cancer Centre (PMCC) were surveyed about their perceptions of PA, the barriers that prevent them from being physically active, and their level of PA currently. Multivariable logistic regression evaluated the associations between clinical and socio-demographic factors on these perceptions and current activity levels. Analyses were adjusted for performance status and important covariates. Results: Cancer survivors were surveyed at a median of 26 months after diagnosis. 16% had breast, 12% GI, 26% gyne/GU, 14% head and neck, 6% lung and 19% hematologic cancers. 55% of survivors reported being physically active. Overall, 76% believed PA could lessen their fatigue, 91% reported PA could improve their QOL, and 89% felt PA could improve their 5-year survival. Common barriers to PA were: being too ill (41%), too tired (33%), too busy (29%) and having too many home responsibilities (28%). Older patients were more likely to believe that PA would not improve their fatigue (p=0.005) and not improve their 5-year survival (p=0.001). Lower household income was associated with belief in lack of benefit of PA on fatigue (p=0.0001) or QOL (p=0.02). Not perceiving benefit of PA on fatigue, QOL, or survival was associated with substantially lower levels of PA (p<0.01; each comparison), as was being older and having a lower income (p=<0.01, each comparison). Conclusions: Older patients (even those with good performance status) and those coming from a lower socioeconomic status were more likely to have negative perceptions of the effect of PA on major cancer outcomes, resulting in lower PA levels. At PMCC, we are using this information to shape how we communicate with our patients in our survivorship program to help them with their decision-making on PA.
Collapse
Affiliation(s)
- Hiten Naik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Xin Qiu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Dan Pringle
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Catherine Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lawson Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Mary Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henrique Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Kyoko Tiessen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henry Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Valerie Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Christina Gonos
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Rebecca Charow
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Vivien Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Margaret Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lindsay Herzog
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Anthea Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Jennifer M. Jones
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
239
|
Herzog L, Howell D, Moura S, Qiu X, Brown C, Vennettilli A, Eng L, Chen L, Malik N, Zvetkova S, Zarrin A, Dobriya A, Patel D, Xu W, Townsley C, Liu G. Quality care and patient involvement in their care: Preferences for transitioning cancer follow-up care to the community. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.30_suppl.75] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
75 Background: The cancer survivor rate is rising and a new focus has turned to the appropriate survivorship care for this new population. Although several models of survivorship care are currently present in Canada, few studies have examined cancer patient preferences. This study compared patient preferences for direct referral back to one’s primary care practitioner (PCP) after 2-3 years of oncology specialist care versustransition through a specialized transitional clinic before exclusive follow-up by one’s PCP. The main objectives were to: (1) assess patient interest in a specialized cancer transitional clinic model, and (2) compare patient and demographic characteristics by such preferences. Methods: A cross-sectional scenario-based survey of cancer survivors who had undergone curative therapy at the Princess Margaret Cancer Centre assessed patient preferences for the transitioning of their post-treatment cancer care. Regression models compared clinico-demographic and psychosocial variables (anxiety, depression, distress) to one’s preference for transition of care. Results: Among 242 cancer survivors, 54% were male, 78% Caucasian, 43% with a college degree, median household income between 60-75K, 71% married, with a wide distribution of curable cancer sites (anal, colorectal, breast, testicular, lymphoma, head/neck, lung). 77% preferred transition through a specialized transitional clinic versus direct referral back to their family doctor. No factors were found to be related to preference for transition of care, except individuals who scored high on anxiety using the ESAS scale were significantly more likely to prefer referral to the specialized transitional clinic (p<0.05). No differences in preference were found by other clinico-demographic factors. Conclusions: A specialized transitional clinic is a preferred survivorship option in three-quarters of cancer patients. Anxiety, but not other variables, was associated with preference for the specialized clinic. This study highlights the need for individual decision-making regarding survivorship options. This individualization of transitioning may help improve patient’s perception of quality cancer care.
Collapse
Affiliation(s)
- Lindsay Herzog
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Shari Moura
- Women's College Hospital, Toronto, ON, Canada
| | - Xin Qiu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Catherine Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Ashlee Vennettilli
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lawson Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Linda Chen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Noor Malik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Svetlana Zvetkova
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Aein Zarrin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Aditi Dobriya
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Devalben Patel
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | | | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
240
|
Wang H, Jiang W, Xu C, Qiu X. [Systemic complications of functional endoscopic sinus surgery in patients with chronic rhinosinusitis]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014; 28:1569-1572. [PMID: 25764755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE To analyses the causes and prevention of systemic complications of functional endoscopic sinus surgery (FESS) in patients with chronic rhinosinusitis. METHOD Three typical cases were reported including their medical history, preoperative diagnosis, medications during preoperational period, complications and treatment. The causes and preventive measures of systemic complications were analyzed. RESULT Three patients were all suffered from chronic rhinosinusitis with nasal polyps (CRSwNP). After FESS, 1 case was complicated with coma and hyponatremia, 1 case with acute myocardial infarction, and 1 case with lower extremity deep venous thrombosis. The patient with coma and hyponatremia was soon waked after intravenous infusion of 10% sodium chloride. Two patients with acute myocardial infarction and lower extremity deep venous thrombosis were soon completely rehabilitated after emergency thrombolytic therapy and endovascular intervention. Three patients were completed recovered from their systemic complications without any severe sequela. CONCLUSION Systemic hemostatic drugs should be banned in patients with hypercoagulable state in perioperation period of FESS in order to avoid severe systemic complications. Timely vascular interventional treatment can prevent severe sequels.
Collapse
|
241
|
So WK, Fan Q, Lau MT, Qiu X, Cheng JC, Leung PCK. Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression. FEBS Lett 2014; 588:3998-4007. [PMID: 25261255 DOI: 10.1016/j.febslet.2014.09.017] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2014] [Revised: 09/05/2014] [Accepted: 09/11/2014] [Indexed: 11/17/2022]
Abstract
Aberrant epidermal growth factor receptor (EGFR) activation is associated with ovarian cancer progression. In this study, we report that the EGFR ligand amphiregulin (AREG) stimulates cell invasion and down-regulates E-cadherin expression in two human ovarian cancer cell lines, SKOV3 and OVCAR5. In addition, AREG increases the expression of transcriptional repressors of E-cadherin including SNAIL, SLUG and ZEB1. siRNA targeting SNAIL or SLUG abolishes AREG-induced cell invasion. Moreover, ERK1/2 and AKT pathways are involved in AREG-induced E-cadherin down-regulation and cell invasion. Finally, we show that three EGFR ligands, AREG, epidermal growth factor (EGF) and transforming growth factor-α (TGF-α), exhibit comparable effects in down-regulating E-cadherin and promoting cell invasion. This study demonstrates that AREG induces ovarian cancer cell invasion by down-regulating E-cadherin expression.
Collapse
Affiliation(s)
- Wai-Kin So
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Qianlan Fan
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Man-Tat Lau
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Xin Qiu
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Jung-Chien Cheng
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
| | - Peter C K Leung
- Department of Obstetrics and Gynecology, Child & Family Research Institute, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada.
| |
Collapse
|
242
|
Ladha S, Ehrnhoefer D, Tsang M, Qiu X, Hayden M. M08 Laquinimod Reduces Neuronal Caspase-6 Activation And Axonal Degeneration In Vitro. Journal of Neurology, Neurosurgery & Psychiatry 2014. [DOI: 10.1136/jnnp-2014-309032.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
243
|
Abstract
Elevated expression of cyclooxygenase 2 (COX2 (PTGS2)) has been reported to occur in human ovarian cancer and to be associated with poor prognosis. We have previously demonstrated that COX2-derived prostaglandin E2 (PGE2) promotes human ovarian cancer cell invasion. We had also demonstrated that epidermal growth factor (EGF) induces human ovarian cancer cell invasion by downregulating the expression of E-cadherin through various signaling pathways. However, it remains unclear whether COX2 and PGE2 are involved in the EGF-induced downregulation of E-cadherin expression and cell invasion in human ovarian cancer cells. In this study, we showed that EGF treatment induces COX2 expression and PGE2 production in SKOV3 and OVCAR5 human ovarian cancer cell lines. Interestingly, COX2 is not required for the EGF-induced downregulation of E-cadherin expression. In addition, EGF treatment activates the phosphatidylinositol-3-kinase (PI3K)/Akt and cAMP response element-binding protein (CREB) signaling pathways, while only the PI3K/Akt pathway is involved in EGF-induced COX2 expression. Moreover, we also showed that EGF-induced cell invasion is attenuated by treatment with a selective COX2 inhibitor, NS-398, as well as PGE2 siRNA. This study demonstrates an important role for COX2 and its derivative, PGE2, in the mediation of the effects of EGF on human ovarian cancer cell invasion.
Collapse
Affiliation(s)
- Xin Qiu
- Department of Obstetrics and GynaecologyChild and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
| | - Jung-Chien Cheng
- Department of Obstetrics and GynaecologyChild and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
| | - Hsun-Ming Chang
- Department of Obstetrics and GynaecologyChild and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
| | - Peter C K Leung
- Department of Obstetrics and GynaecologyChild and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4
| |
Collapse
|
244
|
Korover I, Muangma N, Hen O, Shneor R, Sulkosky V, Kelleher A, Gilad S, Higinbotham DW, Piasetzky E, Watson JW, Wood SA, Aguilera P, Ahmed Z, Albataineh H, Allada K, Anderson B, Anez D, Aniol K, Annand J, Armstrong W, Arrington J, Averett T, Badman T, Baghdasaryan H, Bai X, Beck A, Beck S, Bellini V, Benmokhtar F, Bertozzi W, Bittner J, Boeglin W, Camsonne A, Chen C, Chen JP, Chirapatpimol K, Cisbani E, Dalton MM, Daniel A, Day D, de Jager CW, De Leo R, Deconinck W, Defurne M, Flay D, Fomin N, Friend M, Frullani S, Fuchey E, Garibaldi F, Gaskell D, Gilman R, Glamazdin O, Gu C, Gueye P, Hamilton D, Hanretty C, Hansen JO, Hashemi Shabestari M, Holmstrom T, Huang M, Iqbal S, Jin G, Kalantarians N, Kang H, Khandaker M, LeRose J, Leckey J, Lindgren R, Long E, Mammei J, Margaziotis DJ, Markowitz P, Marti Jimenez-Arguello A, Meekins D, Meziani Z, Michaels R, Mihovilovic M, Monaghan P, Munoz Camacho C, Norum B, Pan K, Phillips S, Pomerantz I, Posik M, Punjabi V, Qian X, Qiang Y, Qiu X, Rakhman A, Reimer PE, Riordan S, Ron G, Rondon-Aramayo O, Saha A, Schulte E, Selvy L, Shahinyan A, Sirca S, Sjoegren J, Slifer K, Solvignon P, Sparveris N, Subedi R, Tireman W, Wang D, Weinstein LB, Wojtsekhowski B, Yan W, Yaron I, Ye Z, Zhan X, Zhang J, Zhang Y, Zhao B, Zhao Z, Zheng X, Zhu P, Zielinski R. Probing the repulsive core of the nucleon-nucleon interaction via the (4)He(e,e'pN) triple-coincidence reaction. Phys Rev Lett 2014; 113:022501. [PMID: 25062168 DOI: 10.1103/physrevlett.113.022501] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/13/2014] [Indexed: 06/03/2023]
Abstract
We studied simultaneously the (4)He(e,e'p), (4)He(e,e'pp), and (4)He(e,e'pn) reactions at Q(2)=2(GeV/c)(2) and x(B)>1, for an (e,e'p) missing-momentum range of 400 to 830 MeV/c. The knocked-out proton was detected in coincidence with a proton or neutron recoiling almost back to back to the missing momentum, leaving the residual A=2 system at low excitation energy. These data were used to identify two-nucleon short-range correlated pairs and to deduce their isospin structure as a function of missing momentum, in a region where the nucleon-nucleon (NN) force is expected to change from predominantly tensor to repulsive. The abundance of neutron-proton pairs is reduced as the nucleon momentum increases beyond ∼500 MeV/c. The extracted fraction of proton-proton pairs is small and almost independent of the missing momentum. Our data are compared with calculations of two-nucleon momentum distributions in (4)He and discussed in the context of probing the elusive repulsive component of the NN force.
Collapse
Affiliation(s)
- I Korover
- Tel Aviv University, Tel Aviv 69978, Israel
| | - N Muangma
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - O Hen
- Tel Aviv University, Tel Aviv 69978, Israel
| | - R Shneor
- Tel Aviv University, Tel Aviv 69978, Israel
| | - V Sulkosky
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA and Longwood University, Farmville, Virginia 23909, USA
| | - A Kelleher
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Gilad
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - D W Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - J W Watson
- Kent State University, Kent, Ohio 44242, USA
| | - S A Wood
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - P Aguilera
- Institut de Physique Nucléaire (UMR 8608), CNRS/IN2P3-Université Paris-Sud, F-91406 Orsay Cedex, France
| | - Z Ahmed
- Syracuse University, Syracuse, New York 13244, USA
| | - H Albataineh
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - K Allada
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - B Anderson
- Kent State University, Kent, Ohio 44242, USA
| | - D Anez
- Saint Mary's University, Halifax, Nova Scotia, Canada
| | - K Aniol
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | - J Annand
- University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom
| | - W Armstrong
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - J Arrington
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - T Averett
- College of William and Mary, Williamsburg, Virginia 23187, USA
| | - T Badman
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - H Baghdasaryan
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - X Bai
- China Institute of Atomic Energy, Beijing, China
| | - A Beck
- Nuclear Research Center Negev, Beer-Sheva, Israel
| | - S Beck
- Nuclear Research Center Negev, Beer-Sheva, Israel
| | - V Bellini
- Universita di Catania, Catania, Italy
| | - F Benmokhtar
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - W Bertozzi
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Bittner
- Longwood University, Farmville, Virginia 23909, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33199, USA
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Chen
- Hampton University, Hampton, Virginia 23668, USA
| | - J-P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - K Chirapatpimol
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - E Cisbani
- INFN, Sezione Sanità and Istituto Superiore di Sanità, 00161 Rome, Italy
| | - M M Dalton
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Daniel
- Ohio University, Athens, Ohio 45701, USA
| | - D Day
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - C W de Jager
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA and University of Virginia, Charlottesville, Virginia 22904, USA
| | - R De Leo
- INFN, Sezione di Bari and University of Bari, I-70126 Bari, Italy
| | - W Deconinck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Defurne
- CEA Saclay, F-91191 Gif-sur-Yvette, France
| | - D Flay
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - N Fomin
- University of Tennessee, Knoxville, Tennessee 37996, USA
| | - M Friend
- Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
| | - S Frullani
- INFN, Sezione Sanità and Istituto Superiore di Sanità, 00161 Rome, Italy
| | - E Fuchey
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - F Garibaldi
- INFN, Sezione Sanità and Istituto Superiore di Sanità, 00161 Rome, Italy
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Gilman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA and Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - O Glamazdin
- Kharkov Institute of Physics and Technology, Kharkov 61108, Ukraine
| | - C Gu
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| | - P Gueye
- Hampton University, Hampton, Virginia 23668, USA
| | - D Hamilton
- University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom
| | - C Hanretty
- Florida State University, Tallahassee, Florida 32306, USA
| | - J-O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - T Holmstrom
- Longwood University, Farmville, Virginia 23909, USA
| | - M Huang
- Duke University, Durham, North Carolina 27708, USA
| | - S Iqbal
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | - G Jin
- University of Virginia, Charlottesville, Virginia 22904, USA
| | | | - H Kang
- Seoul National University, Seoul, Korea
| | - M Khandaker
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J LeRose
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Leckey
- Indiana University, Bloomington, Indiana 47405, USA
| | - R Lindgren
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - E Long
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - J Mammei
- Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - D J Margaziotis
- California State University, Los Angeles, Los Angeles, California 90032, USA
| | - P Markowitz
- Florida International University, Miami, Florida 33199, USA
| | | | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - P Monaghan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA and Hampton University, Hampton, Virginia 23668, USA
| | | | - B Norum
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - K Pan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - S Phillips
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - I Pomerantz
- Tel Aviv University, Tel Aviv 69978, Israel and The University of Texas at Austin, Austin, Texas 78712, USA
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - V Punjabi
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - X Qian
- Duke University, Durham, North Carolina 27708, USA
| | - Y Qiang
- Duke University, Durham, North Carolina 27708, USA
| | - X Qiu
- Lanzhou University, Lanzhou, China
| | - A Rakhman
- Syracuse University, Syracuse, New York 13244, USA
| | - P E Reimer
- Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - S Riordan
- University of Virginia, Charlottesville, Virginia 22904, USA and University of Massachusetts, Amherst, Massachusetts 01006, USA
| | - G Ron
- Racah Institute of Physics, Hebrew University of Jerusalem, Jerusalem, Israel
| | - O Rondon-Aramayo
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - A Saha
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Schulte
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - L Selvy
- Kent State University, Kent, Ohio 44242, USA
| | - A Shahinyan
- Yerevan Physics Institute, Yerevan 375036, Armenia
| | - S Sirca
- University of Ljubljana, Ljubljana, Slovenia
| | - J Sjoegren
- University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom
| | - K Slifer
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - P Solvignon
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - N Sparveris
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R Subedi
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Tireman
- Northern Michigan University, Marquette, Michigan 49855, USA
| | - D Wang
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L B Weinstein
- Old Dominion University, Norfolk, Virginia 23529, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - W Yan
- University of Science and Technology, Hefei, China
| | - I Yaron
- Tel Aviv University, Tel Aviv 69978, Israel
| | - Z Ye
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - X Zhan
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Zhang
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y Zhang
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - B Zhao
- College of William and Mary, Williamsburg, Virginia 23187, USA
| | - Z Zhao
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - P Zhu
- University of Science and Technology, Hefei, China
| | - R Zielinski
- University of New Hampshire, Durham, New Hampshire 03824, USA
| |
Collapse
|
245
|
Abstract
We applied a gene-based haplotype approach for the genome-wide association analysis on hypertension using Genetic Analysis Workshop 18 data for unrelated individuals. Association of single-nucleotide polymorphisms and clinical outcome were first assessed and haplotypes were then constructed based on the gene information and the linkage disequilibrium plot. Extensive haplotype analysis was also conducted for the whole chromosome 3. We found 1 block from the ULK4 gene and 2 blocks from the LOC64690 gene that were significantly associated with hypertension.
Collapse
Affiliation(s)
- Xiaowei Shen
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9 ; Department of Statistics and Actuarial Science, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 4G1
| | - Osvaldo Espin-Garcia
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9 ; Department of Statistics and Actuarial Science, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 4G1
| | - Xin Qiu
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
| | - Yonathan Brhane
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Toronto, Ontario, Canada M5T 3L9
| | - Geoffrey Liu
- Ontario Cancer Institute/Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9 ; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario, Canada M5T 3M7
| | - Wei Xu
- Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9 ; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario, Canada M5T 3M7
| |
Collapse
|
246
|
Qiu X, Shen X, Espin-Garcia O, Azad AK, Liu G, Xu W. Genetic association analysis using weighted false discovery rate approach on Genetic Analysis Workshop 18 data. BMC Proc 2014; 8:S76. [PMID: 25519404 PMCID: PMC4143671 DOI: 10.1186/1753-6561-8-s1-s76] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
In a genome-wide association study, association between disease trait and hundreds of thousands of genetic markers are tested. Several methods have been proposed to control the false discovery rate in such high-throughput data to adjust for multiple hypotheses testing. For Genetic Analysis Workshop 18, we applied the method of false discovery rate control with p value weighting on family-based association tests on quantitative trait to detect association between single-nucleotide polymorphisms (SNPs) and mean arterial pressure. This method can improve statistical power by incorporating independent but relevant information about the research objective. Using the real genetic and phenotype data of chromosome 3 from Genetic Analysis Workshop 18, 1 SNP from gene CACNA2D3 was found to have significant association with mean arterial pressure.
Collapse
Affiliation(s)
- Xin Qiu
- Department of Biostatistics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada
| | - Xiaowei Shen
- Department of Biostatistics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada
| | - Osvaldo Espin-Garcia
- Department of Biostatistics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada
| | - Abul Kalam Azad
- Ontario Cancer Institute, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada
| | - Geoffrey Liu
- Department of Biostatistics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada ; Ontario Cancer Institute, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada ; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, M5T 3M7, Canada
| | - Wei Xu
- Department of Biostatistics, Princess Margaret Cancer Center, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada ; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, M5T 3M7, Canada
| |
Collapse
|
247
|
Eng L, Su J, Qiu X, Brown MC, Naik H, Pringle D, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Pat V, Irwin M, Herzog L, Ho A, Xu W, Jones JM, Howell D, Liu G. Social and perceptual influences on alcohol consumption in cancer survivors. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.9575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Lawson Eng
- Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON, Canada
| | - Jie Su
- Princess Margaret Hospital, Toronto, ON, Canada
| | - Xin Qiu
- Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON, Canada
| | - M Catherine Brown
- Princess Margaret Cancer Centre-University Health Network-Ontario Cancer Institute, Toronto, ON, Canada
| | - Hiten Naik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Dan Pringle
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Mary Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henrique Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Kyoko Tiessen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henry Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Valerie Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Christina Gonos
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Vivien Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Margaret Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lindsay Herzog
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Anthea Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Jennifer M. Jones
- Princess Margaret Cancer Centre, Ontario Cancer Institute, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
248
|
Naik H, Eng L, Brown C, Qiu X, Pringle D, Mahler M, Hon H, Tiessen K, Thai H, Ho V, Gonos C, Charow R, Pat V, Irwin M, Herzog L, Ho A, Xu W, Jones JM, Howell D, Liu G. Socioeconomic status and lifestyle behaviors in cancer survivors. J Clin Oncol 2014. [DOI: 10.1200/jco.2014.32.15_suppl.6568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Hiten Naik
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lawson Eng
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Catherine Brown
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Xin Qiu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Dan Pringle
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Mary Mahler
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henrique Hon
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Kyoko Tiessen
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Henry Thai
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Valerie Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Christina Gonos
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Rebecca Charow
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Vivien Pat
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Margaret Irwin
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Lindsay Herzog
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Anthea Ho
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Wei Xu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Jennifer M. Jones
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Doris Howell
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| | - Geoffrey Liu
- Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON, Canada
| |
Collapse
|
249
|
Adamson P, Anghel I, Aurisano A, Barr G, Bishai M, Blake A, Bock GJ, Bogert D, Cao SV, Castromonte CM, Cherdack D, Childress S, Coelho JAB, Corwin L, Cronin-Hennessy D, de Jong JK, Devan AV, Devenish NE, Diwan MV, Escobar CO, Evans JJ, Falk E, Feldman GJ, Frohne MV, Gallagher HR, Gomes RA, Goodman MC, Gouffon P, Graf N, Gran R, Grzelak K, Habig A, Hahn SR, Hartnell J, Hatcher R, Himmel A, Holin A, Huang J, Hylen J, Irwin GM, Isvan Z, James C, Jensen D, Kafka T, Kasahara SMS, Koizumi G, Kordosky M, Kreymer A, Lang K, Ling J, Litchfield PJ, Lucas P, Mann WA, Marshak ML, Mayer N, McGivern C, Medeiros MM, Mehdiyev R, Meier JR, Messier MD, Michael DG, Miller WH, Mishra SR, Moed Sher S, Moore CD, Mualem L, Musser J, Naples D, Nelson JK, Newman HB, Nichol RJ, Nowak JA, O'Connor J, Orchanian M, Pahlka RB, Paley J, Patterson RB, Pawloski G, Perch A, Phan-Budd S, Plunkett RK, Poonthottathil N, Qiu X, Radovic A, Rebel B, Rosenfeld C, Rubin HA, Sanchez MC, Schneps J, Schreckenberger A, Schreiner P, Sharma R, Sousa A, Tagg N, Talaga RL, Thomas J, Thomson MA, Tian X, Timmons A, Tognini SC, Toner R, Torretta D, Tzanakos G, Urheim J, Vahle P, Viren B, Weber A, Webb RC, White C, Whitehead L, Whitehead LH, Wojcicki SG, Zwaska R. Combined analysis of νμ disappearance and νμ→νe appearance in MINOS using accelerator and atmospheric neutrinos. Phys Rev Lett 2014; 112:191801. [PMID: 24877929 DOI: 10.1103/physrevlett.112.191801] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2014] [Indexed: 06/03/2023]
Abstract
We report on a new analysis of neutrino oscillations in MINOS using the complete set of accelerator and atmospheric data. The analysis combines the ν(μ) disappearance and ν(e) appearance data using the three-flavor formalism. We measure |Δm(32)(2)| = [2.28-2.46] × 10(-3) eV(2) (68% C.L.) and sin(2)θ(23) = 0.35-0.65 (90% C.L.) in the normal hierarchy, and |Δm(32)(2)| = [2.32-2.53] × 10(-3) eV(2) (68% C.L.) and sin(2)θ(23) = 0.34-0.67 (90% C.L.) in the inverted hierarchy. The data also constrain δ(CP), the θ(23} octant degeneracy and the mass hierarchy; we disfavor 36% (11%) of this three-parameter space at 68% (90%) C.L.
Collapse
Affiliation(s)
- P Adamson
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Anghel
- Argonne National Laboratory, Argonne, Illinois 60439, USA and Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011 USA
| | - A Aurisano
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA
| | - G Barr
- Subdepartment of Particle Physics, University of Oxford, Oxford OX1 3RH, United Kingdom
| | - M Bishai
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Blake
- Cavendish Laboratory, University of Cambridge, Madingley Road, Cambridge CB3 0HE, United Kingdom
| | - G J Bock
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Bogert
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S V Cao
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - C M Castromonte
- Instituto de Física, Universidade Federal de Goiás, CP 131, 74001-970 Goiânia, GO, Brazil
| | - D Cherdack
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - S Childress
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J A B Coelho
- Universidade Estadual de Campinas, IFGW-UNICAMP, CP 6165, 13083-970 Campinas, SP, Brazil and Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - L Corwin
- Indiana University, Bloomington, Indiana 47405, USA
| | | | - J K de Jong
- Subdepartment of Particle Physics, University of Oxford, Oxford OX1 3RH, United Kingdom
| | - A V Devan
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - N E Devenish
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - M V Diwan
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C O Escobar
- Universidade Estadual de Campinas, IFGW-UNICAMP, CP 6165, 13083-970 Campinas, SP, Brazil
| | - J J Evans
- School of Physics and Astronomy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
| | - E Falk
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - G J Feldman
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - M V Frohne
- Holy Cross College, Notre Dame, Indiana 46556, USA
| | - H R Gallagher
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - R A Gomes
- Instituto de Física, Universidade Federal de Goiás, CP 131, 74001-970 Goiânia, GO, Brazil
| | - M C Goodman
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - P Gouffon
- Instituto de Física, Universidade de São Paulo, CP 66318, 05315-970 São Paulo, SP, Brazil
| | - N Graf
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA and Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - R Gran
- Department of Physics, University of Minnesota Duluth, Duluth, Minnesota 55812, USA
| | - K Grzelak
- Department of Physics, University of Warsaw, Hoża 69, PL-00-681 Warsaw, Poland
| | - A Habig
- Department of Physics, University of Minnesota Duluth, Duluth, Minnesota 55812, USA
| | - S R Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Hartnell
- Department of Physics and Astronomy, University of Sussex, Falmer, Brighton BN1 9QH, United Kingdom
| | - R Hatcher
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Himmel
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - A Holin
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - J Huang
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - J Hylen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G M Irwin
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - Z Isvan
- Brookhaven National Laboratory, Upton, New York 11973, USA and Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - C James
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Jensen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - T Kafka
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - S M S Kasahara
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - G Koizumi
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Kordosky
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - A Kreymer
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Lang
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - J Ling
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P J Litchfield
- University of Minnesota, Minneapolis, Minnesota 55455, USA and Rutherford Appleton Laboratory, Science and Technologies Facilities Council, Didcot OX11 0QX, United Kingdom
| | - P Lucas
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - M L Marshak
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - N Mayer
- Indiana University, Bloomington, Indiana 47405, USA and Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - C McGivern
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M M Medeiros
- Instituto de Física, Universidade Federal de Goiás, CP 131, 74001-970 Goiânia, GO, Brazil
| | - R Mehdiyev
- Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - J R Meier
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - M D Messier
- Indiana University, Bloomington, Indiana 47405, USA
| | - D G Michael
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - W H Miller
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - S R Mishra
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - S Moed Sher
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C D Moore
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Mualem
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - J Musser
- Indiana University, Bloomington, Indiana 47405, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - H B Newman
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - R J Nichol
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - J A Nowak
- University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J O'Connor
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - M Orchanian
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - R B Pahlka
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Paley
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R B Patterson
- Lauritsen Laboratory, California Institute of Technology, Pasadena, California 91125, USA
| | - G Pawloski
- University of Minnesota, Minneapolis, Minnesota 55455, USA and Department of Physics, Stanford University, Stanford, California 94305, USA
| | - A Perch
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - S Phan-Budd
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R K Plunkett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - N Poonthottathil
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - X Qiu
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - A Radovic
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom and Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - B Rebel
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Rosenfeld
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - H A Rubin
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - M C Sanchez
- Argonne National Laboratory, Argonne, Illinois 60439, USA and Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011 USA
| | - J Schneps
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - A Schreckenberger
- University of Minnesota, Minneapolis, Minnesota 55455, USA and Department of Physics, University of Texas at Austin, 1 University Station C1600, Austin, Texas 78712, USA
| | - P Schreiner
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - R Sharma
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Sousa
- Department of Physics, University of Cincinnati, Cincinnati, Ohio 45221, USA and Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - N Tagg
- Otterbein College, Westerville, Ohio 43081, USA
| | - R L Talaga
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - J Thomas
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - M A Thomson
- Cavendish Laboratory, University of Cambridge, Madingley Road, Cambridge CB3 0HE, United Kingdom
| | - X Tian
- Department of Physics and Astronomy, University of South Carolina, Columbia, South Carolina 29208, USA
| | - A Timmons
- School of Physics and Astronomy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
| | - S C Tognini
- Instituto de Física, Universidade Federal de Goiás, CP 131, 74001-970 Goiânia, GO, Brazil
| | - R Toner
- Cavendish Laboratory, University of Cambridge, Madingley Road, Cambridge CB3 0HE, United Kingdom and Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - G Tzanakos
- Department of Physics, University of Athens, GR-15771 Athens, Greece
| | - J Urheim
- Indiana University, Bloomington, Indiana 47405, USA
| | - P Vahle
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - B Viren
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Weber
- Subdepartment of Particle Physics, University of Oxford, Oxford OX1 3RH, United Kingdom and Rutherford Appleton Laboratory, Science and Technologies Facilities Council, Didcot OX11 0QX, United Kingdom
| | - R C Webb
- Physics Department, Texas A&M University, College Station, Texas 77843, USA
| | - C White
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - L Whitehead
- Brookhaven National Laboratory, Upton, New York 11973, USA and Department of Physics, University of Houston, Houston, Texas 77204, USA
| | - L H Whitehead
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - S G Wojcicki
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R Zwaska
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| |
Collapse
|
250
|
Qiu X, Zheng SL, Wang Y, Wang R, Ye L. A Rapid and Simple UPLC-MS-MS Method for Determination of Glipizide in Human Plasma and Its Application to Bioequivalence Study. J Chromatogr Sci 2014; 53:85-9. [DOI: 10.1093/chromsci/bmu023] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|